DNA Script

France

Retour au propriétaire

1-100 de 130 pour DNA Script Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 111
        Marque 19
Juridiction
        International 72
        États-Unis 46
        Canada 12
Date
Nouveautés (dernières 4 semaines) 1
2026 mai 1
2026 (AACJ) 5
2025 13
2024 25
Voir plus
Classe IPC
C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides 77
C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7) 42
B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés 14
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN 14
C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR] 11
Voir plus
Classe NICE
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 19
09 - Appareils et instruments scientifiques et électriques 19
05 - Produits pharmaceutiques, vétérinaires et hygièniques 16
10 - Appareils et instruments médicaux 15
42 - Services scientifiques, technologiques et industriels, recherche et conception 15
Voir plus
Statut
En Instance 26
Enregistré / En vigueur 104
  1     2        Prochaine page

1.

METHODS AND PRODUCTS FOR REMOVAL OF URACIL CONTAINING POLYNUCLEOTIDES

      
Numéro d'application 19122511
Statut En instance
Date de dépôt 2023-10-18
Date de la première publication 2026-05-21
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Soskine, Mikhael
  • Chua, Puay Suan Jasmine
  • Loftie-Eaton, Wesley
  • Champion, Elise

Abrégé

The present invention relates to the use of a DNA glycosylase enzyme for removing or blocking uracil containing polynucleotides, and methods incorporating the use of such enzymes to remove or block uracil containing poly nucleotides from polynucleotide containing compositions, particularly in methods of template-free DNA synthesis The present invention further relates to methods of tethering polynucleotides to a surface or molecule using a DNA glycosylase enzyme, the resulting products therefrom, and to modified DNA glycosylase enzymes.

Classes IPC  ?

  • C12N 9/24 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

2.

METHOD OF PURIFYING SOLUTION COMPRISING POLYNUCLEOTIDE

      
Numéro d'application 18993240
Statut En instance
Date de dépôt 2023-07-13
Date de la première publication 2026-01-29
Propriétaire DNA Script (France)
Inventeur(s)
  • Kellal, Mouaadh
  • Belin, Paul

Abrégé

The invention relates to a method of purifying a solution comprising newly synthetized polynucleotides, particularly in the field of polynucleotide synthesis such as enzymatic polynucleotide synthesis. The invention also relates to a device configured to carry out the purification method.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

3.

INKJET-ASSISTED ENZYMATIC NUCLEIC ACID SYNTHESIS AND CLEAVAGE

      
Numéro d'application EP2025070586
Numéro de publication 2026/017834
Statut Délivré - en vigueur
Date de dépôt 2025-07-18
Date de publication 2026-01-22
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Thomee, Emma
  • Moghaddam, Nicolas
  • Capela, Cécilia
  • Adelizzi, Beatrice

Abrégé

Methods, devices, and compositions are provided for inkjet-assisted synthesis and recovery of a plurality of polynucleotides at reaction sites on a substrate comprising cleavable initiator nucleic acids, using template-free polymerases. Compositions include printable stabile formulations of cleavage reagents for inkjet delivery including, but not limited to, endonucleases, pH buffer and magnesium.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C09D 11/04 - Encres d’imprimerie à base de protéines
  • C09D 11/38 - Encres pour l'impression à jet d'encre caractérisées par des additifs non macromoléculaires autres que les solvants, les pigments ou les colorants
  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)

4.

FILTERING DEVICE AND METHOD FOR POLYNUCLEOTIDE ENZYMATIC SYNTHESIS

      
Numéro d'application EP2025068852
Numéro de publication 2026/008711
Statut Délivré - en vigueur
Date de dépôt 2025-07-02
Date de publication 2026-01-08
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Heinisch, Tillmann
  • Horgan, Adrian

Abrégé

The present invention is directed to methods and device for template-free enzymatic synthesis of polynucleotides using a filtering barrier.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12M 1/40 - Appareillage spécialement destiné à l'utilisation d'enzymes libres, immobilisées ou liées à un support, p. ex. appareils contenant un lit fluidisé d'enzymes immobilisées

5.

METHOD FOR ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2025068860
Numéro de publication 2026/008717
Statut Délivré - en vigueur
Date de dépôt 2025-07-02
Date de publication 2026-01-08
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Heinisch, Tillmann
  • Soskine, Mikhael
  • Mellare, Morgane
  • Khodaverdi, Keywan
  • Mendes, Clara

Abrégé

The present invention relates to a method of synthesizing a polynucleotide, wherein the method comprises the steps of (a) performing a cycle comprising the steps of (i) contacting a template- independent polymerase with an initiator nucleic acid and a 3'-O-protected nucleoside triphosphate, so that the initiator nucleic acid is elongated by the template-independent polymerase activity by incorporation of the 3' -O-protected nucleoside triphosphate, to form a 3'-O-protected elongated initiator nucleic acid, (ii) deprotecting the 3'-O-protected elongated initiator nucleic acid to form an elongated nucleic acid having a free 3'- hydroxyl, (b) repeating cycles of step (a) to further elongate the initiator nucleic acid, until the polynucleotide is synthesized, wherein the template-independent polymerase is anchored to a solid support during cycles of step (a). The invention further relates to polymerases, kits, solid supports, devices for use in the invention and related uses.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C07K 19/00 - Peptides hybrides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 11/00 - Enzymes fixées sur un support ou immobiliséesCellules microbiennes fixées sur un support ou immobiliséesLeur préparation

6.

SYSTEMS, APPARATUS AND KITS FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application 19241170
Statut En instance
Date de dépôt 2025-06-17
Date de la première publication 2025-12-04
Propriétaire DNA Script (France)
Inventeur(s)
  • Martin, Carl
  • Artigue, Marc
  • Creton, Sandrine
  • De Crozals, Gabriel
  • Godron, Xavier
  • Horgan, Adrian
  • Lachaize, Henri
  • Luckey, John
  • Peponnet, Christine
  • Ybert, Thomas

Abrégé

The invention is directed to systems, apparatus and kits for automated synthesis of a plurality of polynucleotides in an array of reaction chambers using a template-free polymerase. In some embodiments, adaptive elements and processes are provided to monitor and control disruption of the synthesis process and fluid movement by enzyme aggregation.

Classes IPC  ?

  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés

7.

METHODS AND KITS FOR ENZYMATIC SYNTHESIS OF G4-PRONE POLYNUCLEOTIDES

      
Numéro d'application 18285014
Statut En instance
Date de dépôt 2022-04-01
Date de la première publication 2025-09-11
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • De Crozals, Gabriel
  • De Revel, Emmanuel
  • Lachaize, Henri
  • Horgan, Adrian
  • Godron, Xavier

Abrégé

The present invention is directed to methods, compositions and kits for template-free enzymatic synthesis of polynucleotides having sequences capable of forming G-quadruplex (G4) structures. In accordance with the invention elongation reactions affected by G4 formation are carried out in the presence of polyC oligonucleotides, such as polyC initiators, that inhibit or prevent formation of either intra-strand or inter-strand G4 structures.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

8.

VARIANTS OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE AND USES THEREOF

      
Numéro d'application 19088754
Statut En instance
Date de dépôt 2025-03-24
Date de la première publication 2025-07-10
Propriétaire
  • DNA Script (France)
  • Institut Pasteur (France)
  • Centre National De La Recherche Scientifique (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Ybert, Thomas
  • Delarue, Marc

Abrégé

The present invention relates to variants of Terminal deoxynucleotidyl Transferase (TdT), each of which (i) has an amino acid sequence similarity to SEQ ID NO: 2, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33 or 35 with corresponding amino acid substitutions, (ii) is capable of synthesizing a nucleic acid fragment without a template and (iii) is capable of incorporating a modified nucleotide into the nucleic acid fragment.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli

9.

MASSIVELY PARALLEL ENZYMATIC SYNTHESIS OF NUCLEIC ACID STRANDS

      
Numéro d'application 19087343
Statut En instance
Date de dépôt 2025-03-21
Date de la première publication 2025-07-03
Propriétaire DNA Script (France)
Inventeur(s)
  • Horgan, Adrian
  • Godron, Xavier
  • Ybert, Thomas
  • Nicol, Robert

Abrégé

The invention is directed to methods for massively parallel template-free enzymatic synthesis of a plurality of different polynucleotides of predetermined sequences. In one aspect, methods of the invention employ large scale arrays of reaction sites each associated with at least one working electrode for controlling deprotection and deblocking steps at predetermined user selected sites. In another aspect, the invention provides template-free enzymatic synthesis with proofreading, wherein completed polynucleotides at predetermined reaction sites are sequenced using a sequencing by synthesis technique, particularly employing electrochemically labile blocking groups.

Classes IPC  ?

  • C40B 50/06 - Procédés biochimiques, p. ex. utilisant des enzymes ou des micro-organismes viables entiers
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G16B 50/00 - TIC pour la programmation d’outils ou de systèmes de bases de données spécialement adaptées à la bio-informatique

10.

AUTOMATION STATION FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application 18845784
Statut En instance
Date de dépôt 2023-03-10
Date de la première publication 2025-06-26
Propriétaire DNA Script (France)
Inventeur(s)
  • Lachaize, Henri
  • Belin, Paul
  • Mccusker, Sean
  • Hao, Grace
  • Martin, Carl
  • Perez, Jared
  • Artigue, Marc

Abrégé

An apparatus (500) for enzymatic synthesis of a plurality of polynucleotides, the apparatus (500) comprising: a first of a plurality of well plates (502, 902, 804, 904, 806, 906) having a first number of reaction wells: a second of the plurality of well plates (502, 902, 804, 904, 806, 906) having the first number of wells arranged to correspond to the reaction wells of the first well plate; and a vacuum transfer station (1000) configured with a plate lifting platform (1006) that is moved vertically by a horizontally driven wedge-shaped component (1004), the plate lifting platform (1006) being configured to move vertically to raise and lower the second well plate, wherein when the first well plate is moved to and placed on the vacuum transfer station (1000) above the second well plate, the wedge-shaped component (1004) raises the plate lifting platform (1006) to position the second well plate to a predetermined distance (D1, D2, D3, D4) from the first well plate.

Classes IPC  ?

  • B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
  • B01L 9/00 - Dispositifs de supportDispositifs de serrage

11.

NOVEL VARIANTS OF ENDONUCLEASE V FOR CLEAVAGE OF LABELLED DNA

      
Numéro d'application EP2024087133
Numéro de publication 2025/132603
Statut Délivré - en vigueur
Date de dépôt 2024-12-18
Date de publication 2025-06-26
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Molina, Manon
  • Loftie-Eaton, Wesley
  • Martos Marques, Jose
  • Soskine, Mikhael

Abrégé

The present invention relates to novel polypeptides having increased endonuclease V activity and uses thereof, in particular for cleaving labelled DNA.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12P 21/00 - Préparation de peptides ou de protéines

12.

STABILIZED VARIANTS OF HIGHLY ACTIVE ENDONUCLEASE V FOR CLEAVAGE OF LABELLED DNA

      
Numéro d'application EP2024087177
Numéro de publication 2025/132627
Statut Délivré - en vigueur
Date de dépôt 2024-12-18
Date de publication 2025-06-26
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Molina, Manon
  • Loftie-Eaton, Wesley
  • Martos Marques, Jose
  • Soskine, Mikhael

Abrégé

The present invention relates to novel polypeptides having increased endonuclease V activity and uses thereof, in particular for cleaving labelled DNA.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/22 - Ribonucléases

13.

REAGENTS AND METHODS USED IN DEPROTECTION OF 3'-O-AMINO POLYNUCLEOTIDES

      
Numéro d'application 18931309
Statut En instance
Date de dépôt 2024-10-30
Date de la première publication 2025-05-15
Propriétaire DNA Script (France)
Inventeur(s)
  • Aparin, Ilya
  • Soskine, Mikhael
  • Wu, Weidong
  • Veillet, Adeline

Abrégé

This disclosure relates to an enzymatic method of synthesizing a polynucleotide, comprising a deprotecting step which uses as a deprotecting agent a specific phosphonate compound. It also pertains to a method for deprotecting 3′-O-amino elongated fragments of a polynucleotide in an enzymatic method of synthesizing a polynucleotide, comprising contacting the elongated fragments with this phosphonate compound. This disclosure further relates to a kit for synthesizing a polynucleotide comprising one or more vials of synthesis reagents, at least one of which contains an effective amount of a phosphonate compound and to a specific method for preparing said phosphonate compound.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C07F 9/38 - Acides phosphoniques [R—P(:O)(OH)2]Acides thiophosphoniques
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6869 - Méthodes de séquençage

14.

3'-O-AMINOOXYMETHYL BLOCKED NUCLEOTIDES AND USE THEREOF IN ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2024080794
Numéro de publication 2025/093659
Statut Délivré - en vigueur
Date de dépôt 2024-10-31
Date de publication 2025-05-08
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Aparin, Ilya
  • Wu, Weidong
  • Mendes, Clara
  • Villain, Guillaume

Abrégé

This invention relates to a 3'-O-blocked nucleotide having an aminooxymethyl blocking group. It further relates to an enzymatic method of synthesizing a polynucleotide, using this 3'-O-blocked nucleotide. This invention also pertains to a method for preparing this compound and to nucleotide and nucleoside intermediates obtained during its synthesis. This invention further relates to a kit for synthesizing a polynucleotide comprising one or more vials of synthesis reagents, at least one of which contains an effective amount of this 3'-O- blocked nucleotide or a precursor thereof.

Classes IPC  ?

  • C07H 19/073 - Radicaux pyrimidine avec un désoxy-2 ribosyle comme radical saccharide
  • C07H 19/173 - Radicaux purine avec un désoxy-2 ribosyle comme radical saccharide
  • C07H 21/00 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques
  • C07H 21/04 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques avec le désoxyribosyle comme radical saccharide
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques

15.

NOVEL TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) VARIANTS AND USES THEREOF

      
Numéro d'application EP2024080046
Numéro de publication 2025/088024
Statut Délivré - en vigueur
Date de dépôt 2024-10-24
Date de publication 2025-05-01
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Soskine, Mikhael
  • Jaziri, Faten
  • Mellare, Morgane
  • Degrotte, Florent
  • Molina, Manon
  • Mendes, Clara
  • Le Coz, Yann

Abrégé

The invention relates to novel DNA polymerases of the polX family, and in particular Terminal deoxynucleotidyl Transferase (TdT) variants comprising specific mutations or substitutions, and to their uses.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

16.

NOVEL TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TdT) VARIANT AND USES THEREOF

      
Numéro d'application 18709292
Statut En instance
Date de dépôt 2022-11-10
Date de la première publication 2025-01-30
Propriétaire DNA Script (France)
Inventeur(s)
  • Mchale, Daniel
  • Degrotte, Florent
  • Jaziri, Faten
  • Soskine, Mikhael
  • Sune, Elodie
  • Champion, Elise

Abrégé

The invention states to a novel DNA polymerase of the polX family, in particular a Terminal deoxynucleotidyl Transferase (TdT) variants comprising specific mutations or substitutions and their uses.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

17.

METHOD FOR GENERATING A PLURALITY OF POLYNUCLEOTIDES

      
Numéro d'application EP2024071282
Numéro de publication 2025/021984
Statut Délivré - en vigueur
Date de dépôt 2024-07-26
Date de publication 2025-01-30
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Loftie-Eaton, Wesley
  • Raffier, Cerise
  • Champion, Elise
  • Godron, Xavier
  • Soskine, Mikhael

Abrégé

The present application relates to methods and kits for generating a plurality of polynucleotides from a single stranded nucleic acid which comprises the plurality of polynucleotides and at least one cleavable linker comprising two different special nucleotides and using two different endonucleases, the first cleaving 5' of the first special nucleotide and the second cleaving 3' of the second special nucleotide and thereby releasing releasing scarless polynucleotides deprived of the cleavable linker.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
  • C07H 21/00 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques

18.

NUCLEIC ACID SYNTHESIS ON REUSABLE SUPPORT

      
Numéro d'application EP2024068301
Numéro de publication 2025/003434
Statut Délivré - en vigueur
Date de dépôt 2024-06-28
Date de publication 2025-01-02
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Godron, Xavier
  • Fournier, Maxime
  • Boul, Manon

Abrégé

The present invention relates to methods for synthesizing polynucleotides, particularly on a reusable solid surface. The present invention also relates to a kit for use with said methods, and to methods for storing information.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]

19.

SALT ADDITION DURING ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application EP2024066486
Numéro de publication 2024/256604
Statut Délivré - en vigueur
Date de dépôt 2024-06-13
Date de publication 2024-12-19
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Lachaize, Henri
  • Profit, Ludivine

Abrégé

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides using a step of addition of salt compounds during the polynucleotide's elongation.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

20.

REAGENT USED IN DEPROTECTION OF 3'-O-AMINO POLYNUCLEOTIDES

      
Numéro de document 03288702
Statut En instance
Date de dépôt 2024-05-02
Date de disponibilité au public 2024-11-07
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Aparin, Ilya
  • Soskine, Mikhael
  • Wu, Weidong
  • Veillet, Adeline

Classes IPC  ?

  • C07F 9/38 - Acides phosphoniques [R—P(:O)(OH)2]Acides thiophosphoniques
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

21.

Reagents and methods used in deprotection of 3'-O-amino polynucleotides

      
Numéro d'application 18654906
Numéro de brevet 12163172
Statut Délivré - en vigueur
Date de dépôt 2024-05-03
Date de la première publication 2024-11-07
Date d'octroi 2024-12-10
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Aparin, Ilya
  • Soskine, Mikhael
  • Wu, Weidong
  • Veillet, Adeline

Abrégé

This disclosure relates to an enzymatic method of synthesizing a polynucleotide, comprising a deprotecting step which uses as a deprotecting agent a specific phosphonate compound. It also pertains to a method for deprotecting 3′-O-amino elongated fragments of a polynucleotide in an enzymatic method of synthesizing a polynucleotide, comprising contacting the elongated fragments with this phosphonate compound. This disclosure further relates to a kit for synthesizing a polynucleotide comprising one or more vials of synthesis reagents, at least one of which contains an effective amount of a phosphonate compound and to a specific method for preparing said phosphonate compound.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C07F 9/38 - Acides phosphoniques [R—P(:O)(OH)2]Acides thiophosphoniques
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6869 - Méthodes de séquençage

22.

REAGENT USED IN DEPROTECTION OF 3'-O-AMINO POLYNUCLEOTIDES

      
Numéro d'application EP2024062042
Numéro de publication 2024/227846
Statut Délivré - en vigueur
Date de dépôt 2024-05-02
Date de publication 2024-11-07
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Aparin, Ilya
  • Soskine, Mikhael
  • Wu, Weidong
  • Veillet, Adeline

Abrégé

This invention relates to an enzymatic method of synthesizing a polynucleotide, comprising a deprotecting step which uses as a deprotecting agent a specific phosphonate compound. It also pertains to a method for deprotecting 3'-O-amino elongated fragments of a polynucleotide in an enzymatic method of synthesizing a polynucleotide, comprising contacting the elongated fragments with this phosphonate compound. This invention further relates to a kit for synthesizing a polynucleotide comprising one or more vials of synthesis reagents, at least one of which contains an effective amount of a phosphonate compound and to a specific method for preparing said phosphonate compound.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C07F 9/38 - Acides phosphoniques [R—P(:O)(OH)2]Acides thiophosphoniques

23.

METHOD FOR GENERATING DOUBLE-STRANDED NUCLEIC ACID

      
Numéro d'application 18686319
Statut En instance
Date de dépôt 2022-07-22
Date de la première publication 2024-10-24
Propriétaire DNA Script (France)
Inventeur(s)
  • Creton, Sandrine
  • Mahe, Florence

Abrégé

The present invention relates to a method for generating a double-stranded nucleic acid having a predetermined sequence and a method for producing a double-stranded polynucleotide of interest. The invention further relates to a kit for the implementation of said methods.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12N 9/00 - Enzymes, p. ex. ligases (6.)ProenzymesCompositions les contenantProcédés pour préparer, activer, inhiber, séparer ou purifier des enzymes
  • C12N 9/22 - Ribonucléases

24.

ELECTROCHEMICAL DEVICE FOR ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application FR2024050477
Numéro de publication 2024/213852
Statut Délivré - en vigueur
Date de dépôt 2024-04-11
Date de publication 2024-10-17
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Fournier, Maxime
  • Godron, Xavier
  • Boul, Manon
  • Chen, Suyue

Abrégé

The present invention relates to an electrochemical device (1) for enzymatic synthesis of polynucleotides, comprising at least one circulation duct (4) configured to receive an electrolytic solution, the circulation duct (4) being delimited by a first wall (6) and a second wall (7) opposite each other, the first wall (6) forming a support plate (8) of at least one reaction site configured for the enzymatic synthesis and able to carry a polynucleotide initiator fragment, the circulation duct (4) being equipped with a set of electrodes (2), the set of electrodes comprising at least one electrode of an array of electrodes (10) formed on the support plate (8) and operatively associated with the reaction sites, the set of electrodes (2) also comprising at least one additional electrode (16) arranged on the second wall (7) opposite the support plate (8).

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions

25.

ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES USING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE TRIPHOSPHATE MONOMERS

      
Numéro d'application 18568729
Statut En instance
Date de dépôt 2022-06-10
Date de la première publication 2024-08-22
Propriétaire DNA Script (France)
Inventeur(s) Horgan, Adrian

Abrégé

The invention is directed to improvements to methods of enzymatic synthesis of polynucleotides employing 3′-O-amino-nucleoside triphosphate monomers in which aldehyde scavenging agents which are O-substituted hydroxy lamines or polyhydroxylamines reduce or prevent spurious capping of growing polynucleotide chains. thereby increasing yields of full length product.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

26.

ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDE PROBES

      
Numéro d'application EP2024051963
Numéro de publication 2024/156896
Statut Délivré - en vigueur
Date de dépôt 2024-01-26
Date de publication 2024-08-02
Propriétaire DNA SCRIPT (France)
Inventeur(s) Ybert, Thomas

Abrégé

The present invention is directed to methods for enzymatic synthesis of labeled polynucleotide probes using template-free DNA polymerases.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques

27.

Variants of terminal deoxynucleotidyl transferase and uses thereof

      
Numéro d'application 18636074
Numéro de brevet 12286652
Statut Délivré - en vigueur
Date de dépôt 2024-04-15
Date de la première publication 2024-08-01
Date d'octroi 2025-04-29
Propriétaire
  • DNA Script (France)
  • Institut Pasteur (France)
  • Centre National de la Recherche Scientifque (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Ybert, Thomas
  • Delarue, Marc

Abrégé

The present invention relates to variants of Terminal deoxynucleotidyl Transferase (TdT), each of which (i) has an amino acid sequence similarity to SEQ ID NO: 2, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33 or 35 with corresponding amino acid substitutions, (ii) is capable of synthesizing a nucleic acid fragment without a template and (iii) is capable of incorporating a modified nucleotide into the nucleic acid fragment.

Classes IPC  ?

  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

28.

SCARLESS TEMPLATE-FREE ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2024050931
Numéro de publication 2024/153642
Statut Délivré - en vigueur
Date de dépôt 2024-01-16
Date de publication 2024-07-25
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Adelizzi, Beatrice
  • Rodriguez-Pinzon, Daniel
  • Thomee, Emma

Abrégé

Methods are provided for template-free enzymatic synthesis of polynucleotides on a solid support using double cleavage to produce scarless polynucleotides. In particular, methods are disclosed that use an initiator that comprises a cleavable group, which can be cleaved by a small molecule chemical agent, adjusting pH, heat, or photocleaved by illumination with light to release polynucleotides from a solid support after enzymatic synthesis is completed, and an enzymatic cleavage site, which can be cleaved by a cleavage enzyme to remove polynucleotide scars.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C40B 50/14 - Synthèse en phase solide, c.-à-d. dans laquelle au moins un bloc servant à créer la bibliothèque est lié à un support solide au cours de la création de la bibliothèqueProcédés particuliers de clivage à partir du support solide

29.

INKJET-ASSISTED ENZYMATIC NUCLEIC ACID SYNTHESIS

      
Numéro d'application EP2024050932
Numéro de publication 2024/153643
Statut Délivré - en vigueur
Date de dépôt 2024-01-16
Date de publication 2024-07-25
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Moghaddam, Nicolas
  • Adelizzi, Beatrice
  • Loman, Tessa
  • Verardo, Damiano
  • Rodriguez-Pinzon, Daniel
  • Horgan, Adrian

Abrégé

Methods, devices, and compositions are provided for inkjet-assisted synthesis of a plurality of polynucleotides at reaction sites on a substrate using template-free polymerases, such as, terminal deoxynucleotidyl transferases (TdTs). Compositions include printable stabile formulations of synthesis reagents for inkjet delivery including, but not limited to, template-free polymerases, divalent cations, and nucleotides.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B41M 1/00 - Encrage et impression avec une forme d'impression
  • C09D 11/38 - Encres pour l'impression à jet d'encre caractérisées par des additifs non macromoléculaires autres que les solvants, les pigments ou les colorants
  • C09D 11/54 - Encres à base de deux liquides, l’un des liquides étant l’encre, l’autre liquide étant une solution de réaction, un fixateur ou une solution de traitement pour l’encre
  • B41M 5/00 - Procédés de reproduction ou méthodes de reproduction ou de marquageMatériaux en feuilles utilisés à cet effet

30.

METHODS FOR OBTAINING CORRECTLY ASSEMBLED NUCLEIC ACIDS

      
Numéro d'application EP2024050196
Numéro de publication 2024/146937
Statut Délivré - en vigueur
Date de dépôt 2024-01-05
Date de publication 2024-07-11
Propriétaire DNA SCRIPT (France)
Inventeur(s) Jeddeloh, Jeffrey

Abrégé

Methods, systems, and devices are provided for identification and selective amplification of a correctly assembled nucleic acid comprising a sequence of interest from a mixture of assembled nucleic acids. In some aspects, the inventions use split-pool enzymatic DNA synthesis to add a bead-specific index sequence to bead-bound clonally amplified assembled nucleic acids. High-throughput sequencing is used to identify beads comprising correctly assembled, sequence-perfect nucleic acids. A correctly assembled nucleic acid may be selectively amplified using a primer comprising a sequence that is complementary to the bead-specific index sequence that is associated with the correctly assembled nucleic acid.

Classes IPC  ?

  • C12Q 1/6855 - Adaptateurs ligaturés
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]

31.

HEAT TREATMENT MEANS FOR PRINTING DEVICE OF AN ENZYMATIC SYNTHESIS APPARATUS

      
Numéro d'application EP2023087966
Numéro de publication 2024/141629
Statut Délivré - en vigueur
Date de dépôt 2023-12-29
Date de publication 2024-07-04
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano

Abrégé

The present invention relates to a printing device (1) configured for the enzymatic synthesis of biomolecules, comprising a printing head (2), at least one ink reservoir (7) containing synthesis reagents and a substrate plate (16) configured to receive ink drops (6), the printing device (1) being equipped with heat treatment means (26) configured to generate a positive temperature differential between the print head (2) and/ or the ink reservoir (7) on the one hand and the substrate plate (16) on the other.

Classes IPC  ?

  • C12M 1/26 - Inoculateur ou échantillonneur
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés

32.

VARIABLE VISCOSITY INKS FOR INKJET DELIVERY OF ENZYME REAGENTS

      
Numéro d'application EP2023087965
Numéro de publication 2024/141628
Statut Délivré - en vigueur
Date de dépôt 2023-12-29
Date de publication 2024-07-04
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Adelizzi, Beatrice

Abrégé

The invention is directed to formulations of terminal deoxynucleotidyl transferases (TdTs) inks employing variable viscosity modifiers and their use in inkjet assisted synthesis of a plurality of polynucleotides at reaction sites on a substrate.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • B41M 5/00 - Procédés de reproduction ou méthodes de reproduction ou de marquageMatériaux en feuilles utilisés à cet effet
  • C09D 11/38 - Encres pour l'impression à jet d'encre caractérisées par des additifs non macromoléculaires autres que les solvants, les pigments ou les colorants
  • B41M 1/00 - Encrage et impression avec une forme d'impression
  • C09D 11/328 - Encres pour l'impression à jet d'encre caractérisées par des agents colorants caractérisées par des colorants

33.

VARIANTS OF POLY(A) POLYMERASE AND USES THEREOF

      
Numéro d'application EP2023084053
Numéro de publication 2024/121022
Statut Délivré - en vigueur
Date de dépôt 2023-12-04
Date de publication 2024-06-13
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Heinisch, Tillmann
  • Morris, Elinor
  • Mellare, Morgane
  • Villain, Guillaume
  • Mendes, Clara
  • Champion, Elise
  • Soskine, Mikhael

Abrégé

The present invention relates to poly(A) polymerase variants having several amino acid modifications which confer increased stability, increased activity and increased purity of the polynucleotides obtained therefrom during template-free polynucleotide synthesis. The present invention further relates to use of the variant enzymes for synthesising polynucleotides, methods of synthesising polynucleotides comprising the variant enzymes, and kits comprising the variant enzyme.

Classes IPC  ?

  • C12N 9/10 - Transférases (2.)
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

34.

IN VITRO ENZYMATICAL RNA SYNTHESIS

      
Numéro d'application EP2023084831
Numéro de publication 2024/121360
Statut Délivré - en vigueur
Date de dépôt 2023-12-08
Date de publication 2024-06-13
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Heinisch, Tillmann
  • Villain, Guillaume
  • Derrien, Benoit
  • Lourenco, Nelly

Abrégé

The present invention relates to nucleic acid constructs capable of generating an RNA product, methods and kits for generating RNA products using said nucleic acid constructs.

Classes IPC  ?

  • C12N 15/11 - Fragments d'ADN ou d'ARNLeurs formes modifiées
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

35.

METHODS AND PRODUCTS FOR REMOVAL OF URACIL CONTAINING POLYNUCLEOTIDES

      
Numéro d'application EP2023078926
Numéro de publication 2024/083883
Statut Délivré - en vigueur
Date de dépôt 2023-10-18
Date de publication 2024-04-25
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Soskine, Mikhael
  • Chua, Puay Suan Jasmine
  • Loftie-Eaton, Wesley
  • Champion, Elise

Abrégé

The present invention relates to the use of a DNA glycosylase enzyme for removing or blocking uracil containing polynucleotides, and methods incorporating the use of such enzymes to remove or block uracil containing polynucleotides from polynucleotide containing compositions, particularly in methods of template-free DNA synthesis The present invention further relates to methods of tethering polynucleotides to a surface or molecule using a DNA glycosylase enzyme, the resulting products therefrom, and to modified DNA glycosylase enzymes.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/24 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2)

36.

VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY

      
Numéro d'application 18516616
Statut En instance
Date de dépôt 2023-11-21
Date de la première publication 2024-04-18
Propriétaire
  • DNA Script (France)
  • Institut Pasteur (France)
  • Centre National De La Recherche Scientifique (France)
Inventeur(s)
  • Ybert, Thomas
  • Delarue, Marc

Abrégé

The invention relates to variants of a DNA polymerase of the polX family capable of synthesizing a nucleic acid molecule without a template strand, or of a functional fragment of such a polymerase, comprising at least one mutation of a residue in at least one specific position, and to uses of said variants, in particular for the synthesis of nucleic acid molecules comprising 3′-OH modified nucleotides.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

37.

METHOD FOR SYNTHESIZING POLYNUCLEOTIDES USING A MOVE-STOP PRINTER

      
Numéro d'application EP2023078364
Numéro de publication 2024/079270
Statut Délivré - en vigueur
Date de dépôt 2023-10-12
Date de publication 2024-04-18
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Adelizzi, Beatrice
  • Rodriguez-Pinzon, Daniel

Abrégé

Title: Method for synthesizing polynucleotides using a move-stop printer The present invention relates to a method for synthesizing polynucleotides using a move-stop printer ejecting ink droplets, comprising: a set-up step (30) during which sets of instructions are implemented, each set of instructions controlling the functioning of the move-stop printer for a row of reaction sites, each instruction of the sets of instructions controlling the opening of one nozzle; a positioning step (36); a computing step (38); a firing step (40) during which the nozzles eject droplets on at least one reaction site, according to the sets of instructions; a synthesis step (8); a moving step (47); some steps (38, 40, 8, 47) being repeated until every row of reaction sites has been placed under the nozzles of the move-stop printer.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B41J 3/407 - Machines à écrire ou mécanismes d'impression ou de marquage sélectif caractérisés par le but dans lequel ils sont construits pour le marquage sur des matériaux particuliers
  • C12M 1/40 - Appareillage spécialement destiné à l'utilisation d'enzymes libres, immobilisées ou liées à un support, p. ex. appareils contenant un lit fluidisé d'enzymes immobilisées
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p. ex. fermenteurs commandés automatiquement
  • G16Z 99/00 - Matière non prévue dans les autres groupes principaux de la présente sous-classe

38.

Stabilized N-Terminally Truncated Terminal Deoxynucleotidyl Transferase Variants and Uses Thereof

      
Numéro d'application 18027594
Statut En instance
Date de dépôt 2021-09-22
Date de la première publication 2024-03-21
Propriétaire DNA Script (France)
Inventeur(s)
  • Soskine, Mikhael
  • Champion, Elise
  • Mchale, Daniel

Abrégé

The present invention is directed to terminal deoxynucleotidyl transferase (TdT) variants from a variety of species which have been engineered for increase compactness and enhanced efficiency in incorporating reversibly blocked nucleoside triphosphates into a polynucleotide, especially polynucleotides attached porous solid supports. The invention includes use of such TdTs for synthesizing polynucleotides of any predetermined sequence.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

39.

Enzymatic Synthesis of Polynucleotide Probes

      
Numéro d'application 18034487
Statut En instance
Date de dépôt 2021-10-27
Date de la première publication 2024-02-15
Propriétaire DNA Script (France)
Inventeur(s)
  • Godron, Xavier
  • Niyomchon, Supaporn
  • Champion, Elise

Abrégé

The present invention is directed to methods and kits for enzymatic synthesis of labeled polynucleotide probes using template-free DNA polymerases.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)

40.

COVER FOR THE HEAD OF A PRINTING DEVICE FOR THE SYNTHESIS OF BIOMOLECULES

      
Numéro d'application EP2023069277
Numéro de publication 2024/013215
Statut Délivré - en vigueur
Date de dépôt 2023-07-12
Date de publication 2024-01-18
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Adelizzi, Beatrice
  • Rodriguez-Pinzon, Daniel

Abrégé

The present invention relates to a printing device (1) comprising a printing head (2), a supporting platform (18) receiving a substrate plate (16), and a cover (34) for covering the printing head (2), the supporting platform (18) comprising a receiving area (32) for receiving the cover (34) and a receiving area (20) for receiving the substrate plate (16), the supporting platform (18) being movable between a first position with the receiving area (20) facing the printing head (2) and a second position with the receiving area (32) facing the printing head (2), the printing device (1) comprising reversible securing means (38) for reversibly securing the cover (34) to the printing head (2), which are activated according to the position of the supporting platform (18).

Classes IPC  ?

  • C12M 1/40 - Appareillage spécialement destiné à l'utilisation d'enzymes libres, immobilisées ou liées à un support, p. ex. appareils contenant un lit fluidisé d'enzymes immobilisées
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C12M 1/26 - Inoculateur ou échantillonneur
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

41.

COVER FOR A SUBSTRATE PLATE OF AN ENZYMATIC SYNTHESIS APPARATUS

      
Numéro d'application EP2023069281
Numéro de publication 2024/013217
Statut Délivré - en vigueur
Date de dépôt 2023-07-12
Date de publication 2024-01-18
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Adelizzi, Beatrice
  • Rodriguez-Pinzon, Daniel

Abrégé

The present invention relates to an enzymatic synthesis apparatus configured for the synthesis of biomolecules, comprising a support platform (18) having a receiving area configured to receive a substrate plate (16) on which ink drops containing synthesis reagents are disposed, the enzymatic synthesis apparatus comprising a cover (22) for covering the substrate plate (16), the cover (22) being equipped with reversible hooking means (40) for reversibly hooking to a frame (42) of a covering station of the enzymatic synthesis apparatus.

Classes IPC  ?

  • C12M 1/40 - Appareillage spécialement destiné à l'utilisation d'enzymes libres, immobilisées ou liées à un support, p. ex. appareils contenant un lit fluidisé d'enzymes immobilisées
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/30 - Inoculateur ou échantillonneur incorporé au récipient l'échantillonneur étant un tampon
  • C12M 1/26 - Inoculateur ou échantillonneur

42.

SUBSTRATE-PLATE-SUPPORTING PLATFORM FOR AN ENZYMATIC BIOMOLECULE SYNTHESIS APPARATUS

      
Numéro d'application EP2023069270
Numéro de publication 2024/013213
Statut Délivré - en vigueur
Date de dépôt 2023-07-12
Date de publication 2024-01-18
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Verardo, Damiano
  • Artigue, Marc

Abrégé

The present invention relates to a supporting platform (18) configured to receive a substrate plate (16) on which ink drops containing biomolecules are disposed, said platform comprising a main wall (28) on which receiving means (38, 40) are formed in order to receive the substrate plate (16), a recess (32) being provided in a space in the support platform (18), extending from the main wall (28), and the receiving means (38, 40) being arranged around the recess (32) such that the substrate plate (16) is received so as to cover the recess (32).

Classes IPC  ?

  • C12M 1/40 - Appareillage spécialement destiné à l'utilisation d'enzymes libres, immobilisées ou liées à un support, p. ex. appareils contenant un lit fluidisé d'enzymes immobilisées
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C12M 1/26 - Inoculateur ou échantillonneur
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

43.

METHOD OF PURIFYING SOLUTION COMPRISING POLYNUCLEOTIDE

      
Numéro d'application EP2023069431
Numéro de publication 2024/013278
Statut Délivré - en vigueur
Date de dépôt 2023-07-13
Date de publication 2024-01-18
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Kellal, Mouaadh
  • Belin, Paul

Abrégé

The invention relates to a method of purifying a solution comprising newly synthetized polynucleotides, particularly in the field of polynucleotide synthesis such as enzymatic polynucleotide synthesis. The invention also relates to a device configured to carry out the purification method.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

44.

Novel Variants of Endonuclease V and Uses Thereof

      
Numéro d'application 18033787
Statut En instance
Date de dépôt 2021-10-21
Date de la première publication 2023-12-28
Propriétaire DNA Script (France)
Inventeur(s)
  • Loftie-Eaton, Wesley
  • Heinisch, Tillmann
  • Soskine, Mikhael
  • Champion, Elise
  • Godron, Xavier
  • Ybert, Thomas

Abrégé

The present invention relates to novel polypeptides having an endonuclease V activity, and uses thereof.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 9/96 - Stabilisation d'une enzyme par formation d'un adduct ou d'une compositionFormation de conjugaisons d'enzymes

45.

Massively Parallel Enzymatic Synthesis of Polynucleotides

      
Numéro d'application 18014993
Statut En instance
Date de dépôt 2021-07-09
Date de la première publication 2023-10-05
Propriétaire DNA Script (France)
Inventeur(s)
  • Horgan, Adrian
  • Lachaize, Henri
  • Verardo, Domiano
  • Godron, Xavier

Abrégé

The invention is directed to methods and compositions for inkjet assisted synthesis of a plurality of polynucleotides at reaction sites on a substrate using template-free polymerases, such as, terminal deoxynucleotidyl transferases (TdTs). Compositions of the invention include formulations of synthesis reagents for inkjet delivery including, but not limited to, TdT coupling reaction buffers and 3′-O-protected dNTP monomers.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C09D 11/04 - Encres d’imprimerie à base de protéines

46.

MODULAR ACCESSORY RACK

      
Numéro d'application EP2023056144
Numéro de publication 2023/170259
Statut Délivré - en vigueur
Date de dépôt 2023-03-10
Date de publication 2023-09-14
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Mccusker, Sean
  • Martin, Carl

Abrégé

A modular accessory rack (1), comprising a bottom housing (2) having at least two vertically elongated chambers (6), each extending from a bottom surface (21) of the bottom housing (2) to a top edge (22) delimiting a top opening, and at least two sub-racks (4) each removably inserted into the same or different vertically elongated chambers (6) of the bottom housing (2) via the corresponding top opening, wherein each sub-rack (4) has one or more vertically elongated receptacles for holding accessories, and wherein the bottom housing (2) has a front surface bordering the at least two vertically elongated chambers (6), the front surface having at least a U-shaped cutout (27) formed from the top edge (22) delimiting one of the vertically elongated chamber (6).

Classes IPC  ?

  • B01L 9/06 - Supports de tubes à essaiPorte-tubes à essai
  • B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
  • B01L 9/00 - Dispositifs de supportDispositifs de serrage

47.

AUTOMATION STATION FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application EP2023056160
Numéro de publication 2023/170266
Statut Délivré - en vigueur
Date de dépôt 2023-03-10
Date de publication 2023-09-14
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Lachaize, Henri
  • Belin, Paul
  • Mccusker, Sean
  • Hao, Grace
  • Martin, Carl
  • Perez, Jared
  • Artigue, Marc

Abrégé

An apparatus (500) for enzymatic synthesis of a plurality of polynucleotides, the apparatus (500) comprising: a first of a plurality of well plates (502, 902, 804, 904, 806, 906) having a first number of reaction wells; a second of the plurality of well plates (502, 902, 804, 904, 806, 906) having the first number of wells arranged to correspond to the reaction wells of the first well plate; and a vacuum transfer station (1000) configured with a plate lifting platform (1006) that is moved vertically by a horizontally driven wedge-shaped component (1004), the plate lifting platform (1006) being configured to move vertically to raise and lower the second well plate, wherein when the first well plate is moved to and placed on the vacuum transfer station (1000) above the second well plate, the wedge-shaped component (1004) raises the plate lifting platform (1006) to position the second well plate to a predetermined distance (D1, D2, D3, D4) from the first well plate.

Classes IPC  ?

  • B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
  • B01L 9/00 - Dispositifs de supportDispositifs de serrage

48.

APPARATUS FOR ENZYMATIC SYNTHESIS OF A PLURALITY OF POLYNUCLEOTIDES COMPRISING A CONDENSATION TRAP

      
Numéro d'application EP2023056143
Numéro de publication 2023/170258
Statut Délivré - en vigueur
Date de dépôt 2023-03-10
Date de publication 2023-09-14
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Mccusker, Sean
  • Hao, Grace

Abrégé

An apparatus (500) for enzymatic synthesis of a plurality of polynucleotides, the apparatus (500) comprising a chiller (11) with a condensation generating device (8) and a condensation trap (1) comprising a frame with a front surface (2) and an opposing back surface (4) connected by first and second lateral sides (6), wherein the frame houses a U-shaped inner structure that is formed by two opposing inner side surfaces (12) connected by an inner bottom surface (14), wherein the U-shaped inner structure forms a space traversing the frame between the front surface (2) and the back surface (4), the space configured to accommodate a protuberance of the condensation generating device (8), wherein the inner bottom surface (14) comprises a trough (10) configured to collect condensate from the condensation generating device (8), the trough (10) comprising a sloped surface (16) angled downward from a top edge (18) nearest the back surface (4) to a bottom edge (20) nearest the front surface (2), the bottom edge (20) connecting to a first edge (22) of a condensate channel (23), wherein the condensation trap (1) also comprises a plate (24) forming part of the front surface (2) of the frame and forming a vertical wall of the trough along a second edge of the condensate channel (23) across from the first edge (22), wherein the condensate channel (23) slopes downwards, terminating at an aperture (26), wherein the aperture (26) is in fluid communication with a tubing connector (28).

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B01L 3/02 - BurettesPipettes

49.

ALIGNMENT POST AND SECURE MECHANISM FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application EP2023056204
Numéro de publication 2023/170286
Statut Délivré - en vigueur
Date de dépôt 2023-03-10
Date de publication 2023-09-14
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Lachaize, Henri
  • Belin, Paul
  • Mccusker, Sean
  • Luckey, John

Abrégé

Alignment post and secure mechanism for enzymatic polynucleotide synthesis An apparatus (500) for enzymatic synthesis of a plurality of polynucleotides, the apparatus (500) comprising a reagent cabinet (516) configured to receive and 5 hold a reagent rack (540, 560) including a plurality of reagent containers, the reagent cabinet (516) including a cabinet door (514), at least one of the plurality of reagent containers containing an elongation buffer having an elongation enzyme, the reagent rack (540, 560) including a pair of positioning tabs (554, 556) that protrude from an insertion end of the reagent rack (540, 560), such that 10 in a case that the reagent rack (540, 560) is improperly inserted into the reagent cabinet (516), the positioning tabs (554, 556) prevent the cabinet door (514) from properly closing.

Classes IPC  ?

50.

Systems, apparatus and kits for enzymatic polynucleotide synthesis

      
Numéro d'application 18010424
Numéro de brevet 12377397
Statut Délivré - en vigueur
Date de dépôt 2021-06-14
Date de la première publication 2023-08-03
Date d'octroi 2025-08-05
Propriétaire DNA Script (France)
Inventeur(s)
  • Martin, Carl
  • Artigue, Marc
  • Creton, Sandrine
  • De Crozals, Gabriel
  • Godron, Xavier
  • Horgan, Adrian
  • Lachaize, Henri
  • Luckey, John
  • Peponnet, Christine
  • Ybert, Thomas

Abrégé

The invention is directed to systems, apparatus and kits for automated synthesis of a plurality of polynucleotides in an array of reaction chambers using a template-free polymerase. In some embodiments, adaptive elements and processes are provided to monitor and control disruption of the synthesis process and fluid movement by enzyme aggregation.

Classes IPC  ?

  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés

51.

Template-Free Enzymatic Polynucleotide Synthesis Using Dismutationless Terminal Deoxynucleotidyl Transferase Variants

      
Numéro d'application 17786344
Statut En instance
Date de dépôt 2020-12-15
Date de la première publication 2023-06-29
Propriétaire DNA Script (France)
Inventeur(s) Ybert, Thomas

Abrégé

The present invention is directed to the use of terminal deoxynucleotidyltransferase (TdT) variants lacking dismutation acivity for template-free enzymatic synthesis of polynucleotides of any predetermined sequence. Such TdT variants permit higher yields of correct sequence polynucleotides.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

52.

Variants of family a DNA polymerase and uses thereof

      
Numéro d'application 17858801
Numéro de brevet 12173333
Statut Délivré - en vigueur
Date de dépôt 2022-07-06
Date de la première publication 2023-06-22
Date d'octroi 2024-12-24
Propriétaire DNA Script (France)
Inventeur(s)
  • Ybert, Thomas
  • Champion, Elise
  • Vivar, Omar
  • Said, Ahmed

Abrégé

The present invention relates to variant of Family A polymerases able to synthesize a nucleic acid fragment without template and to incorporate a reversible modified terminator nucleotide during the nucleic acid fragment synthesis. The present invention further relates to uses thereof for enzymatic synthesis of nucleic acid molecules.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger

53.

Variants of a DNA Polymerase of the Polx Family

      
Numéro d'application 17815490
Statut En instance
Date de dépôt 2022-07-27
Date de la première publication 2023-06-01
Propriétaire DNA Script (France)
Inventeur(s)
  • Ybert, Thomas
  • Delarue, Marc

Abrégé

The invention relates to variants of a DNA polymerase of the polX family capable of synthesizing a nucleic acid molecule without a template strand, or of a functional fragment of such a polymerase, comprising at least one mutation of a residue in at least one specific position, and to uses of said variants, in particular for the synthesis of nucleic acid molecules comprising 3′-OH modified nucleotides.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

54.

Terminal Deoxynucleotidyl Transferase Variants and Uses Thereof

      
Numéro d'application 17919649
Statut En instance
Date de dépôt 2021-04-16
Date de la première publication 2023-05-25
Propriétaire DNA Script (France)
Inventeur(s)
  • Soskine, Mikhael
  • Champion, Elise

Abrégé

The present invention is directed to terminal deoxynucleotidyl transferase (TdT) variants from a variety of species which display enhanced efficiency in incorporating reversibly blocked nucleoside triphosphates into a polynucleotide, and to the use of such TdTs in synthesizing polynucleotides of any predetermined sequence.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

55.

NOVEL TERMINAL DEOXYNUCLEOTIDYL

      
Numéro d'application EP2022081547
Numéro de publication 2023/083997
Statut Délivré - en vigueur
Date de dépôt 2022-11-10
Date de publication 2023-05-19
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Mchale, Daniel
  • Degrotte, Florent
  • Jaziri, Faten
  • Soskine, Mikhael
  • Sune, Elodie
  • Champion, Elise

Abrégé

The invention states to a novel DNA polymerase of the polX family, in particular a Terminal deoxynucleotidyl Transferase (TdT) variants comprising specific mutations or substitutions and their uses.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

56.

NOVEL TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) VARIANTS

      
Numéro d'application EP2022081551
Numéro de publication 2023/083999
Statut Délivré - en vigueur
Date de dépôt 2022-11-10
Date de publication 2023-05-19
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Mchale, Daniel
  • Degrotte, Florent
  • Jaziri, Faten
  • Sune, Elodie
  • Soskine, Mikhael
  • Champion, Elise

Abrégé

The invention states to a novel DNA polymerase of the polX family, in particular a Terminal deoxynucleotidyl Transferase (TdT) variants comprising specific mutations or substitutions and their uses.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

57.

NOVEL TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) VARIANT AND USES THEREOF

      
Numéro de document 03236657
Statut En instance
Date de dépôt 2022-11-10
Date de disponibilité au public 2023-05-19
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Mchale, Daniel
  • Degrotte, Florent
  • Jaziri, Faten
  • Soskine, Mikhael
  • Sune, Elodie
  • Champion, Elise

Abrégé

The invention states to a novel DNA polymerase of the polX family, in particular a Terminal deoxynucleotidyl Transferase (TdT) variants comprising specific mutations or substitutions and their uses.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

58.

Method and apparatus for enzymatic synthesis of polynucleotides

      
Numéro d'application 17802485
Numéro de brevet 12618092
Statut Délivré - en vigueur
Date de dépôt 2021-02-22
Date de la première publication 2023-03-23
Date d'octroi 2026-05-05
Propriétaire DNA Script (France)
Inventeur(s)
  • Horgan, Adrian
  • Godron, Xavier

Abrégé

The invention is directed to methods and apparatus for parallel enzymatic synthesis of polynucleotides in an array of reaction chambers using a template-free polymerase that has sequence-dependent coupling efficiencies. Whenever sequences causing low efficiency coupling occur at a 3′ end of a growing chain of a polynucleotide being synthesized, one or more additional coupling cycles without de-protection steps are inserted into synthesis plans to provide additional time for completing the coupling reaction at that position of the polynucleotide.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

59.

DNA SCRIPTORS

      
Numéro d'application 1719120
Statut Enregistrée
Date de dépôt 2022-10-14
Date d'enregistrement 2022-10-14
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 35 - Publicité; Affaires commerciales
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, small bottles, cartridges, vials, reaction plates, synthesis supports, reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Administration of loyalty and reward programs; business management and business advisory services; marketing consultancy services; market study; promotion of the sale of third-party goods and services by means of coupons, discounts, advertisements, rewards and incentives generated by the use of electronic links to websites for merchants and retailers and promotional contests; promotion of third-party goods and services through the distribution of printed matter and advertisements; advertising; commercial administration; clerical services (office functions); assistance services for the management of industrial and commercial companies; commercial business appraisal; advisory services for business management; market study; commercial statistical information; drawing up of statements of accounts; accounting; business research; public relations services; publication of advertising texts; publication of publicity leaflets; computerized file management services; processing of information and checking of information; data retrieval services; organization of exhibitions for commercial or advertising purposes; provision of information concerning the purchase of goods and services on line via the Internet and other computer networks; profiling information directory of customer data; advisory and information services in the aforesaid fields; administrative services for medical referrals; commercial administration of the licensing of third-party goods and services; administration of consumer loyalty programs; providing user appraisals for commercial or advertising purposes; compilation of information indexes for commercial or advertising purposes; compilation of information into computer databases; providing user reviews for commercial or advertising purposes; providing business information; providing information with respect to business and commercial contacts; providing commercial information and advice to consumers regarding choice of goods and services. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; server hosting; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

60.

DNA SCRIPT

      
Numéro d'application 1715801
Statut Enregistrée
Date de dépôt 2022-12-07
Date d'enregistrement 2022-12-07
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely DNA and RNA, as well as parts and accessories for such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis supports, reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for synthesis of polynucleotides, namely DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; synthetic DNA design and testing services for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; server hosting; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

61.

Chimeric Terminal Deoxynucleotidyl Transferases For Template-Free Enzymatic Synthesis Of Polynucleotides

      
Numéro d'application 17783186
Statut En instance
Date de dépôt 2020-12-14
Date de la première publication 2023-03-02
Propriétaire DNA Script (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Jaziri, Faten
  • Mchale, Daniel

Abrégé

The invention is directed to compositions and methods for enzymatic template-free synthesis of polynucleotides using terminal deoxynucleotidyl transferases that are chimeras derived from variants from different species.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

62.

METHOD FOR GENERATING DOUBLE-STRANDED NUCLEIC ACID

      
Numéro d'application EP2022070699
Numéro de publication 2023/025488
Statut Délivré - en vigueur
Date de dépôt 2022-07-22
Date de publication 2023-03-02
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Creton, Sandrine
  • Mahe, Florence

Abrégé

The present invention relates to a method for generating a double-stranded nucleic acid having a predetermined sequence and a method for producing a double-stranded polynucleotide of interest. The invention further relates to a kit for the implementation of said methods.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6811 - Méthodes de sélection pour la production ou l’élaboration d’oligonucléotides spécifiques cibles ou de molécules de liaison
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques

63.

SYNTAX

      
Numéro d'application 1715451
Statut Enregistrée
Date de dépôt 2022-07-20
Date d'enregistrement 2022-07-20
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]; all the aforesaid goods other than those directly for use in the cardiovascular field. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use; all the aforesaid goods other than those directly for use in the cardiovascular field. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely DNA and RNA, as well as parts and accessories for such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis supports, reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips; all the aforesaid goods other than those directly for use in the cardiovascular field. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use; all the aforesaid goods other than those directly for use in the cardiovascular field. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; computer services for storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; biological research laboratory services for storage of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; chemical laboratory services for storage of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; scientific services for the storage of nucleic acid molecules, particularly for the amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; computer services for the preservation, storage or processing of data on DNA chips containing information; biological research laboratory services for preservation, storage or processing of data on DNA chips containing information; chemical laboratory services for preservation, storage or processing of data on DNA chips containing information; scientific services for the preservation, storage or processing of data on DNA chips containing information; ; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; server hosting; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage; all the aforesaid services other than those directly for use in the cardiovascular field. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy; all the aforesaid services other than those directly for use in the cardiovascular field.

64.

High Efficiency Template-Free Enzymatic Synthesis of Polynucleotides

      
Numéro d'application 17775845
Statut En instance
Date de dépôt 2020-11-09
Date de la première publication 2022-12-29
Propriétaire DNA Script (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Sune, Elodie
  • Ybert, Thomas
  • Godron, Xavier
  • Heinisch, Tillmann

Abrégé

The invention is directed to compositions and methods for enzymatic template-free synthesis of polynucleotides wherein different terminal deoxynucleotidyl transferase (TdT) variants are used to incorporate different 3′-O-reversibly blocked deoxynucleoside triphosphates (dNTPs) into a growing chain. In part, the invention is a recognition and appreciation that different TdT variants can be engineered to preferentially incorporate specific dNTPs with higher efficiency than a single “general purpose” TdT variant used to incorporate all four 3-O-reversibly blocked dNTPs.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

65.

Miscellaneous Design

      
Numéro d'application 1702770
Statut Enregistrée
Date de dépôt 2022-10-14
Date d'enregistrement 2022-10-14
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 35 - Publicité; Affaires commerciales
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, small bottles, cartridges, vials, reaction plates, synthesis supports, reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Administration of loyalty and reward programs; business management and business advisory services; marketing consultancy services; market study; promotion of the sale of third-party goods and services by means of coupons, discounts, advertisements, rewards and incentives generated by the use of electronic links to websites for merchants and retailers and promotional contests; promotion of third-party goods and services through the distribution of printed matter and advertisements; advertising; commercial administration; clerical services (office functions); assistance services for the management of industrial and commercial companies; commercial business appraisal; advisory services for business management; market study; commercial statistical information; drawing up of statements of accounts; accounting; business research; public relations services; publication of advertising texts; publication of publicity leaflets; computerized file management services; processing of information and checking of information; data retrieval services; organization of exhibitions for commercial or advertising purposes; provision of information concerning the purchase of goods and services on line via the Internet and other computer networks; profiling information directory of customer data; advisory and information services in the aforesaid fields; administrative services for medical referrals; commercial administration of the licensing of third-party goods and services; administration of consumer loyalty programs; providing user appraisals for commercial or advertising purposes; compilation of information indexes for commercial or advertising purposes; compilation of information into computer databases; providing user reviews for commercial or advertising purposes; providing business information; providing information with respect to business and commercial contacts; providing commercial information and advice to consumers regarding choice of goods and services. Technical evaluations concerning design (engineers' services); scientific research; technical research projects and studies; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for others; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; server hosting; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

66.

Increasing Long-Sequence Yields In Template-Free Enzymatic Synthesis of Polynucleotides

      
Numéro d'application 17629322
Statut En instance
Date de dépôt 2020-07-28
Date de la première publication 2022-12-22
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Sarac, Ivo
  • Niyomchon, Supaporn
  • Godron, Xavier

Abrégé

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides using chain elongation conditions that suppress the formation of DNA secondary structures including, but not limited to, intra-strand and between-strand duplexes, G-quadruplexes, and the like. In some embodiments, such chain elongation conditions include using 3′-O-blocked dNTP monomers that base protection groups or base analogs that suppress the formation of hydrogen bonding in the polynucleotide being synthesized.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

67.

Template-free enzymatic synthesis of polynucleotides using poly(A) and poly(U) polymerases

      
Numéro d'application 17629316
Numéro de brevet 12584154
Statut Délivré - en vigueur
Date de dépôt 2020-07-28
Date de la première publication 2022-12-22
Date d'octroi 2026-03-24
Propriétaire DNA Script (France)
Inventeur(s)
  • Heinisch, Tillmann
  • Champion, Elise
  • Sune, Elodie
  • Soskine, Mikhael

Abrégé

The present invention is directed to methods and compositions for template-free enzymatic synthesis of a polyribonucleotide of a predetermined sequence from 3′-O-reversibly blocked nucleoside triphosphates using poly(A) and poly(U) polymerases.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

68.

Increasing long-sequence yields in template-free enzymatic synthesis of polynucleotides

      
Numéro d'application 17636256
Numéro de brevet 12606856
Statut Délivré - en vigueur
Date de dépôt 2020-09-21
Date de la première publication 2022-12-22
Date d'octroi 2026-04-21
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Macevicz, Stephen C.

Abrégé

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides employing hybridization stringency and/or nuclease digestion for removing failure sequences.

Classes IPC  ?

  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6869 - Méthodes de séquençage

69.

Variants of terminal deoxynucleotidyl transferase and uses thereof

      
Numéro d'application 17544647
Numéro de brevet 12071638
Statut Délivré - en vigueur
Date de dépôt 2021-12-07
Date de la première publication 2022-12-22
Date d'octroi 2024-08-27
Propriétaire
  • DNA Script (France)
  • Institut Pasteur (France)
  • Centre National de la Recherche Scientifique (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Ybert, Thomas
  • Delarue, Marc

Abrégé

The present invention relates to variants of Terminal deoxynucleotidyl Transferase (TdT), each of which (i) has an amino acid sequence similarity to SEQ ID NO: 2. 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33 or 35 with corresponding amino acid substitutions, (ii) is capable of synthesizing a nucleic acid fragment without a template and (iii) is capable of incorporating a modified nucleotide into the nucleic acid fragment.

Classes IPC  ?

  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

70.

ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES USING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE TRIPHOSPHATE MONOMERS

      
Numéro d'application EP2022065839
Numéro de publication 2022/258809
Statut Délivré - en vigueur
Date de dépôt 2022-06-10
Date de publication 2022-12-15
Propriétaire DNA SCRIPT (France)
Inventeur(s) Horgan, Adrian

Abrégé

The invention is directed to improvements to methods of enzymatic synthesis of polynucleotides employing 3'-O-amino-nucleoside triphosphate monomers in which aldehyde scavenging agents which are O-substituted hydroxylamines or polyhydroxylamines reduce or prevent spurious capping of growing polynucleotide chains, thereby increasing yields of full length product.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

71.

DNA SCRIPT

      
Numéro d'application 224279800
Statut Enregistrée
Date de dépôt 2022-12-07
Date d'enregistrement 2025-05-02
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Produits chimiques, réactifs, enzymes et kits comprenant des enzymes, monomères, supports solides, plaques de synthèse, tous à utiliser dans la recherche scientifique, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches pour la recherche; cellules souches à usage scientifique; réactifs chimiques pour la recherche génétique; réactif de culture cellulaire pour l'utilisation laboratoire; protéines sous forme de matières premières pour la recherche scientifique. (2) Réactifs chimiques et enzymes à usage médical, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches à usage médical; cellules souches à usage vétérinaire. (3) Appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; accessoires pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir bouteilles, flacons, cartouches, fioles, plaques de réaction, supports de synthèse, tubes de réaction; logiciels informatiques téléchargeables pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; appareils et instruments de laboratoire et appareils et instruments à usage scientifique utilisant et stockant des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; puces à ADN; appareils à usage scientifique pour la conservation, le stockage et le traitement de puces à ADN contenant des informations; matériel informatique et logiciels informatiques destinés à des appareils et instruments pour la synthétisation de polynucléotides; matériel informatique et logiciels informatiques pour la synthèse de polynucléotides, à savoir l'ADN et l'ARN; matériel informatique et logiciels informatiques destinés à l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; matériel informatique et logiciels informatiques destinés à la conservation, le stockage et le traitement de puces à ADN contenant des informations; biopuces. (4) Appareils médicaux pour l'amplification de molécules d'acide nucléique ADN et ARN; appareil médical d'essais génétiques pour l'identification de séquences d'ADN et d'ARN spécifiques de genres et d'espèces; dispositifs de détection de biomolécules de diagnostic et de séquences d'ADN à des fins médicales cliniques; dispositifs d'analyse pour l'identification de bactéries à usage médical. (1) Évaluation de la conception du produit; recherches scientifique dans le domaine de la génétique et du génie génétique; recherches technologiques dans le domaine de la génétique et du génie génétique; recherches biologiques; recherches en chimie; recherches médicales; analyse chimique; services de chimiste; services de laboratoires scientifiques, nommément, laboratoires chimiques, de diagnostics médicaux et de recherche scientifique dans le domaine de la génétique et du génie génétique; services de conception et de test d'ADN synthétique à des fins de recherche scientifique; services de synthèse de polynucléotides, à savoir l'ADN et l'ARN à des fins de recherche scientifique; services de stockage des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; services de conservation, de stockage et de traitement de puces à ADN contenant des informations; conception d'ordinateurs pour des tiers; développement d'ordinateurs; conception de logiciels; développement de logiciels; recherche et développement de nouveaux produits pour des tiers; conduite d'études de projets techniques dans le domaine de la génétique et du génie génétique; élaboration (conception) de logiciels; installation de logiciels; maintenance de logiciels; mise à jour de logiciels; location de logiciels informatiques; programmation pour ordinateurs; analyse de systèmes informatiques; conception de systèmes informatiques; services de conseillers en matière de conception et de développement de matériel informatique; numérisation de documents; logiciel-service (SaaS) pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; fournisseur d'informatique en nuage pour le stockage de données; services de conseil en technologie informatique; services d'hébergement de serveurs; services de conception d'art graphique; services de conception industrielle; authentification d'oeuvres d'art; audits en matière d'énergie; stockage électronique de données pour l'archivage de dossiers personnels, de dossiers médicaux et des résultats de recherches scientifiques dans le domaine de la génétique et du génie génétique. (2) Services médicaux, nommément services d'analyses d'ADN à des fins médicales, d'administration de tests médicaux, d'examens médicaux à des fins de diagnostic ou de traitement, d'examens médicaux en matière de diagnostic et de traitement des maladies, services médicaux dans les domaine de l'oncologie et d'administration de tests génétiques à des fins médicales; services vétérinaires; assistance médicale, nommément fourniture d'informations médicales dans le domaine de la génétique et du génie génétique; chirurgie esthétique; services hospitaliers; services d'analyses médicales fournis par des laboratoires médicaux à des fins diagnostiques et thérapeutiques; consultation génétique; consultation en matière de pharmacie.

72.

DNA SCRIPT

      
Numéro de série 79363945
Statut Enregistrée
Date de dépôt 2022-12-07
Date d'enregistrement 2024-02-27
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; protein in raw material form for scientific researcb Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use Apparatus and instruments for laboratory and scientific use for polynucleotide synthesis in the field of DNA and RNA, namely, pipetors, liquid handlers, laboratory columns for chemical synthesis, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory research instruments for DNA analysis, as well as parts and accessories for such apparatus and instruments, namely, laboratory glassware in the nature of bottles, flasks, cartridges, vials, reaction plates, synthesis supports, and reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; apparatus and instruments for laboratory and scientific use in using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems, namely, laboratory devices for detecting genetic sequences, scientific apparatus and instruments for measuring relative DNA, RNA and protein, electrical equipment for the genetic modification of cells for research purposes, laboratory apparatus and instruments for extracting nucleic acid; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory apparatus and instruments for extracting nucleic acid; computer hardware and recorded and downloadable computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and recorded and downloadable computer software for synthesis of polynucleotides, namely, DNA and RNA; computer hardware and recorded and downloadable computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and recorded and downloadable computer software for use in preserving, storing or processing DNA chips containing information; biochips for scientific research purposes and data storage purposes DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases; analysis devices for identification of bacteria for medical use Technical evaluations concerning design being engineers' services; scientific research; technical research in the field of polynucleotide synthesis; biological research; chemical research; medical research; chemical analysis; chemistry services, namely, research and laboratory analysis in the field of chemistry; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA synthesis for scientific research purposes; scientific and medical laboratory services, namely, encoding or processing DNA chips containing information and data; design of computers for third parties; computer hardware development; software design; software development; research and development of new products for third parties; technical research in the field of DNA and RNA, namely, conducting of technical project studies; software development and design; software installation; software maintenance; updating of software; software rental, namely, rental of computer software for operating apparatus and instruments for DNA and RNA synthesis; computer programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS) featuring software for operating apparatus and instruments for DNA and RNA synthesis; cloud computing featuring software for operating apparatus and instruments for DNA and RNA synthesis; advice regarding information technology, namely, installation, maintenance and troubleshooting of computer software; hosting of servers; graphic arts design services; styling being industrial design services; authentication of works of art; energy auditing; electronic data storage Medical services; veterinary services; cosmetic and medical skin care services for beauty and sanitary care purposes; medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; advice with respect to health in the field of DNA and its preservation; consultation with respect to pharmaceuticals

73.

One pot synthesis of sets of oligonucleotides

      
Numéro d'application 17419637
Numéro de brevet 12428668
Statut Délivré - en vigueur
Date de dépôt 2019-12-26
Date de la première publication 2022-11-10
Date d'octroi 2025-09-30
Propriétaire DNA Script (France)
Inventeur(s)
  • Godron, Xavier
  • Horgan, Adrian

Abrégé

The invention is directed to methods for synthesizing a plurality of oligonucleotides in the same reaction vessel, and in some embodiments, using the synthesized oligonucleotides in an oligonucleotide-based assay in such reaction vessel. In some embodiments, methods of the invention are implemented by steps of (a) providing a plurality of different initiators attached to one or more supports, each different initiator having a terminal nucleotide with a different 3-O-blocking group; (b) for each different initiator, synthesizing a polynucleotide by repeated cycles of template-free enzymatic additions of 3′-O-blocked nucleoside triphosphates, wherein the blocking group of the 3-O-blocked nucleoside triphosphate is removable under deblocking conditions orthogonal to the deblocking conditions for removing blocking groups of the other initiators; and (c) releasing the oligonucleotides from the polynucleotides and the one or more solid supports.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/48 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir une transférase
  • C12Q 1/686 - Réaction en chaine par polymérase [PCR]

74.

Template-Free Enzymatic Polynucleotide Synthesis Using Photocleavable Linkages

      
Numéro d'application 17636326
Statut En instance
Date de dépôt 2020-09-08
Date de la première publication 2022-10-06
Propriétaire DNA Script (France)
Inventeur(s) Horgan, Adrian

Abrégé

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides employing photocleavable linkages. In some embodiments, such methods include using 3′-O—NH2-dNTP monomers which may react with photocleavage products having free ketone to allow synthesis and purification on the same or an added support.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/686 - Réaction en chaine par polymérase [PCR]

75.

METHODS AND KITS FOR ENZYMATIC SYNTHESIS OF G4-PRONE POLYNUCLEOTIDES

      
Numéro d'application EP2022058814
Numéro de publication 2022/207934
Statut Délivré - en vigueur
Date de dépôt 2022-04-01
Date de publication 2022-10-06
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • De Crozals, Gabriel
  • De Revel, Emmanuel
  • Lachaize, Henri
  • Horgan, Adrian
  • Godron, Xavier

Abrégé

The present invention is directed to methods, compositions and kits for template-free enzymatic synthesis of polynucleotides having sequences capable of forming G-quadruplex (G4) structures. In accordance with the invention elongation reactions affected by G4 formation are carried out in the presence of polyC oligonucleotides, such as polyC initiators, that inhibit or prevent formation of either intra-strand or inter-strand G4 structures.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6834 - Couplage enzymatique ou biochimique d’acides nucléiques à une phase solide
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés

76.

DNA SCRIPT

      
Numéro d'application 1679736
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2022-05-25
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely, DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis media, reaction tubes, as well as related computer hardware and software for use in the use and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; hosting of servers; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

77.

RNA SCRIPT

      
Numéro d'application 1679904
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2022-05-25
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely, DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis media, reaction tubes, as well as related computer hardware and software for use in the use and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; hosting of servers; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

78.

DNA SCRIPT

      
Numéro d'application 1679905
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2022-05-25
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material]. Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use. Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely, DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis media, reaction tubes, as well as related computer hardware and software for use in the use and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips. DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use. Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; hosting of servers; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage. Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy.

79.

SYNTAX

      
Numéro d'application 224112000
Statut Enregistrée
Date de dépôt 2022-07-20
Date d'enregistrement 2025-08-01
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Produits chimiques, réactifs, enzymes et kits comprenant des enzymes, monomères, supports solides, plaques de synthèse, tous à utiliser dans la recherche scientifique, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de ou stockant des molécules d'acides nucléiques; cellules souches pour la recherche et à usage scientifique; produits chimiques pour analyses en laboratoire autres qu'à usage médical ou vétérinaire, nommément réactif chimiques pour la recherche génétique; protéine [matière première] nommément enzymes polymérases de l'ADN; tous les produits précités à l'exception de ceux directement destinés au domaine cardiovasculaire. (2) Réactifs chimiques et enzymes à usage médical, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de molécules d'acides nucléiques; Réactifs chimiques et enzymes à usage médical, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques stockant des molécules d'acides nucléiques; cellules souches à usage médical; cellules souches à usage vétérinaire; tous les produits précités à l'exception de ceux directement destinés au domaine cardiovasculaire. (3) Appareils et instruments de laboratoire et appareils et instruments à usage scientifique pour la synthèse de polynucléotides, à savoir synthétiseurs d'ADN et synthétiseurs d'ARN, ainsi que les parties et accessoires de ces appareils et instruments, à savoir bouteilles de laboratoire, flacons de laboratoire, cartouches pour synthétiseurs d'ADN et synthétiseurs d'ARN, fioles de laboratoire, plaques de réaction optique, supports de synthèse solides physiques et chimiques optimisés nommément colonnes chromatographiques de laboratoires, tubes de réaction, matériel informatique et logiciels informatiques téléchargeables permettant l'utilisation synthétiseurs d'ADN et synthétiseurs d'ARN, la connexion et l'intégration de synthétiseurs d'ADN et synthétiseurs d'ARN avec des appareils et instruments pour la synthétisation de polynucléotides; appareils et instruments de laboratoire et appareils et instruments à usage scientifique utilisant et stockant des molécules d'acide nucléique, pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; puces à ADN; appareils à usage scientifique pour la conservation, le stockage et le traitement de puces à ADN contenant des informations; matériel informatique et logiciels informatiques destinés à des appareils et instruments pour la synthétisation de polynucléotides; matériel informatique et logiciels informatiques pour la synthèse de polynucléotides, à savoir l'ADN et l'ARN; matériel informatique et logiciels informatiques destinés à l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; matériel informatique et logiciels informatiques destinés à la conservation, le stockage et le traitement de puces à ADN contenant des informations; biopuces; puces à ADN; tous les produits précités à l'exception de ceux directement destinés au domaine cardiovasculaire. (4) Appareils à usage médical d'essais génétiques pour l'identification de séquences ADN et ARN; appareils pour l'analyse à usage médical, nommément lecteurs de biomolécules diagnostiques et de séquences d'ADN de résultats de tests de biomolécules et de séquences d'ADN pour une utilisation médicale clinique; appareils pour le diagnostic à usage médical, nommément dispositifs de détection de biomolécules de diagnostic et de séquences d'ADN à des fins médicales cliniques; dispositifs d'analyse pour l'identification de bactéries à usage médical; tous les produits précités à l'exception de ceux directement destinés au domaine cardiovasculaire. (1) Évaluations techniques concernant la conception, nommément réalisation d'études de faisabilité techniques, d'analyses et d'évaluations dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; recherches scientifiques dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; recherches techniques dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; recherches biologiques; recherches en chimie; recherches médicales dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; analyse chimique; services de chimie, nommément recherche et conception dans le domaine de la chimie, établissement de rapports en rapport avec la recherche en chimie; services de laboratoires de recherche scientifiques dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; services de conception et de test d'ADN synthétique à des fins de recherche scientifique; services de synthèse de polynucléotides, à savoir l'ADN et l'ARN à des fins de recherche scientifique; services informatiques pour le stockage des molécules d'acide nucléique, pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques sur des puces à ADN contenant des informations; services de laboratoire de recherches biologiques pour le stockage des molécules d'acide nucléique, pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques sur des puces à ADN contenant des informations; services de laboratoires chimiques pour le stockage des molécules d'acide nucléique, pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques sur des puces à ADN contenant des informations; services scientifiques pour le stockage des molécules d'acide nucléique, pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques sur des puces à ADN contenant des informations; services informatiques permettant l'archivage, le stockage, l'analyse et la collecte de données sur des puces à ADN contenant des séquences d'ADN; services de laboratoire de recherches biologiques dans le domaine de la conservation, du stockage et du traitement de données biologiques sur des puces à ADN contenant des informations; services de laboratoires chimiques permettant la conservation, le stockage ou le traitement de données sur des puces à ADN contenant des informations; services scientifiques permettant la conservation, le stockage ou le traitement de données sur des puces à ADN contenant des informations, nommément séquençages d'ADN à des fins de recherches médicales; recherche et développement de nouveaux produits pour des tiers; conduite d'études de projets techniques dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; logiciel-service (SaaS) à savoir fourniture d'un logiciel permettant d'accéder à des informations stockées dans des bases de données dans le domaine de la génétique, de la génomique, de la biologie, du séquençage de l'ADN et de l'ARN; informatique en nuage permettant l'archivage de fichiers contenant des données ADN; services de stylisme et esthétique industrielle, nommément services de design industriel technologique; authentification d'oeuvres d'art; audits en matière d'énergie; stockage électronique de données pour l'archivage de données biologiques sur des puces à ADN; tous les services précités à l'exception de ceux directement destinés au domaine cardiovasculaire. (2) Services médicaux, nommément analyses d'ADN à des fins médicales; services vétérinaires; services pour le soin de la peau nommément, services de soins esthétiques pour la peau; assistance médicale nommément services de soins de relève sous forme de services d'assistance en soins infirmiers; chirurgie esthétique; services de cliniques et d'hôpitaux; conseils en matière de santé mentale, de santé au travail et de la nutrition; tous les services précités à l'exception de ceux directement destinés au domaine cardiovasculaire.

80.

SYNTAX

      
Numéro de série 79363759
Statut Enregistrée
Date de dépôt 2022-07-20
Date d'enregistrement 2025-11-11
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; protein in raw material form for scientific research; all the aforesaid goods other than those directly for use in the cardiovascular field Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use; all the aforesaid goods other than those directly for use in the cardiovascular field Apparatus and instruments for laboratory and scientific use for polynucleotide synthesis in the field of DNA and RNA, namely, pipetors, liquid handlers, laboratory columns for chemical synthesis, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory research instruments for DNA analysis, as well as parts and accessories for such apparatus and instruments, namely, laboratory glassware in the nature of bottles, flasks, cartridges, vials, reaction plates, synthesis supports, and reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; apparatus and instruments for laboratory and scientific use in using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems, namely, laboratory devices for detecting genetic sequences, scientific apparatus and instruments for measuring relative DNA, RNA and protein, electrical equipment for the genetic modification of cells for research purposes, laboratory apparatus and instruments for extracting nucleic acid; DNA chips; Apparatus for scientific use for preservation, storage or processing of DNA chips containing information, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory apparatus and instruments for extracting nucleic acid; computer hardware and recorded and downloadable computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and recorded and downloadable computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and recorded and downloadable computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and recorded and downloadable computer software for use in preserving, storing or processing DNA chips containing information; biochips for scientific research purposes and data storage purposes; all the aforesaid goods other than those directly for use in the cardiovascular field DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases; analysis devices for identification of bacteria for medical use; all the aforesaid goods other than those directly for use in the cardiovascular field Technical research in the field of polynucleotide synthesis; biological research; chemical research; medical research; chemical analysis; chemistry services, namely, research and laboratory analysis in the field of chemistry; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA synthesis for scientific research purposes; computer services for storing nucleic acid molecules, particularly, cloud storage services for electronic data comprising visual representations of nucleic acid molecules for use in amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; biological research laboratory services in the field of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; chemical laboratory services in the field of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; scientific research and laboratory services in the field of nucleic acid molecules, particularly for the amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; computer services for the preservation, storage or processing of data on DNA chips containing information, namely, providing temporary use of online non-downloadable computer software for preserving, storing and processing data in the field of DNA; biological research laboratory services for preservation or processing of data on DNA chips containing information; chemical laboratory services for preservation or processing of data on DNA chips containing information; scientific research and laboratory services for the preservation or processing of data on DNA chips containing information; technical research in the field of DNA and RNA, namely, conducting of technical project studies; software development and design; software rental, namely, rental of computer software for operating apparatus and instruments for DNA and RNA synthesis; digitization of documents; Software as a Service (SaaS) featuring software for operating apparatus and instruments for DNA and RNA synthesis; cloud computing featuring software for operating apparatus and instruments for DNA and RNA synthesis; graphic arts design services; styling being industrial design services; authentication of works of art; energy auditing; all the aforesaid services other than those directly for use in the cardiovascular field Medical services; veterinary services; cosmetic and medical skin care services for beauty and sanitary care purposes; medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; advice with respect to health in the field of DNA and its preservation; consultation with respect to pharmaceuticals; all the aforesaid services other than those directly for use in the cardiovascular field

81.

DNA SCRIPT

      
Numéro d'application 220594500
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2025-05-02
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Produits chimiques, réactifs, enzymes et kits comprenant des enzymes, monomères, supports solides, plaques de synthèse, tous à utiliser dans la recherche scientifique, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches pour la recherche; cellules souches à usage scientifique; réactifs chimiques pour la recherche génétique; réactif de culture cellulaire pour l'utilisation laboratoire; protéines sous forme de matières premières pour la recherche scientifique. (2) Réactifs chimiques et enzymes à usage médical, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches à usage médical; cellules souches à usage vétérinaire. (3) Appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; accessoires pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir bouteilles, flacons, cartouches, fioles, plaques de réaction, supports de synthèse, tubes de réaction; logiciels informatiques pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; appareils et instruments de laboratoire et appareils et instruments à usage scientifique utilisant et stockant des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; puces à ADN; appareils à usage scientifique pour la conservation, le stockage et le traitement de puces à ADN contenant des informations; matériel informatique et logiciels informatiques destinés à des appareils et instruments pour la synthétisation de polynucléotides; matériel informatique et logiciels informatiques pour la synthèse de polynucléotides, à savoir l'ADN et l'ARN; matériel informatique et logiciels informatiques destinés à l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; matériel informatique et logiciels informatiques destinés à la conservation, le stockage et le traitement de puces à ADN contenant des informations; biopuces. (4) Appareils médicaux pour l'amplification de molécules d'acide nucléique ADN et ARN; appareil médical d'essais génétiques pour l'identification de séquences d'ADN et d'ARN spécifiques de genres et d'espèces; dispositifs de détection de biomolécules de diagnostic et de séquences d'ADN à des fins médicales cliniques; dispositifs d'analyse pour l'identification de bactéries à usage médical. (1) Évaluation de la conception du produit; recherches scientifique dans le domaine de la génétique et du génie génétique; recherches technologiques dans le domaine de la génétique et du génie génétique; recherches biologiques; recherches en chimie; recherches médicales; analyse chimique; services de chimiste; services de laboratoires scientifiques, nommément, laboratoires chimiques, de diagnostics médicaux et de recherche scientifique dans le domaine de la génétique et du génie génétique; services de conception et de test d'ADN synthétique à des fins de recherche scientifique; services de synthèse de polynucléotides, à savoir l'ADN et l'ARN à des fins de recherche scientifique; services de stockage des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; services de conservation, de stockage et de traitement de puces à ADN contenant des informations; conception d'ordinateurs pour des tiers; développement d'ordinateurs; conception de logiciels; développement de logiciels; recherche et développement de nouveaux produits pour des tiers; conduite d'études de projets techniques dans le domaine de la génétique et du génie génétique; élaboration (conception) de logiciels; installation de logiciels; maintenance de logiciels; mise à jour de logiciels; location de logiciels informatiques; programmation pour ordinateurs; analyse de systèmes informatiques; conception de systèmes informatiques; services de conseillers en matière de conception et de développement de matériel informatique; numérisation de documents; logiciel-service (SaaS) pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; fournisseur d'informatique en nuage pour le stockage de données; services de conseil en technologie informatique; services d'hébergement de serveurs; services de conception d'art graphique; services de conception industrielle; authentification d'oeuvres d'art; audits en matière d'énergie; stockage électronique de données pour l'archivage de dossiers personnels, de dossiers médicaux et des résultats de recherches scientifiques dans le domaine de la génétique et du génie génétique. (2) Services médicaux, nommément services d'analyses d'ADN à des fins médicales, d'administration de tests médicaux, d'examens médicaux à des fins de diagnostic ou de traitement, d'examens médicaux en matière de diagnostic et de traitement des maladies, services médicaux dans les domaine de l'oncologie et d'administration de tests génétiques à des fins médicales; services vétérinaires; assistance médicale, nommément fourniture d'informations médicales dans le domaine de la génétique et du génie génétique; chirurgie esthétique; services hospitaliers; services d'analyses médicales fournis par des laboratoires médicaux à des fins diagnostiques et thérapeutiques; consultation génétique; consultation en matière de pharmacie.

82.

DNA SCRIPT

      
Numéro d'application 220594800
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2025-05-02
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Produits chimiques, réactifs, enzymes et kits comprenant des enzymes, monomères, supports solides, plaques de synthèse, tous à utiliser dans la recherche scientifique, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches pour la recherche; cellules souches à usage scientifique; réactifs chimiques pour la recherche génétique; réactif de culture cellulaire pour l'utilisation laboratoire; protéines sous forme de matières premières pour la recherche scientifique. (2) Réactifs chimiques et enzymes à usage médical, à savoir à utiliser dans la synthétisation de polynucléotides, à savoir pour l'amplification, l'assemblage, la modification de fragments génétiques, le génotypage, la modification de gènes, et l'analyse de systèmes, échantillons et cellules biologiques, dans des installations et laboratoires cliniques, médicaux et biologiques à l'aide de et stockant des molécules d'acides nucléiques; cellules souches à usage médical; cellules souches à usage vétérinaire. (3) Appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; accessoires pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir bouteilles, flacons, cartouches, fioles, plaques de réaction, supports de synthèse, tubes de réaction; logiciels informatiques pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; appareils et instruments de laboratoire et appareils et instruments à usage scientifique utilisant et stockant des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; puces à ADN; appareils à usage scientifique pour la conservation, le stockage et le traitement de puces à ADN contenant des informations; matériel informatique et logiciels informatiques destinés à des appareils et instruments pour la synthétisation de polynucléotides; matériel informatique et logiciels informatiques pour la synthèse de polynucléotides, à savoir l'ADN et l'ARN; matériel informatique et logiciels informatiques destinés à l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; matériel informatique et logiciels informatiques destinés à la conservation, le stockage et le traitement de puces à ADN contenant des informations; biopuces. (4) Appareils médicaux pour l'amplification de molécules d'acide nucléique ADN et ARN; appareil médical d'essais génétiques pour l'identification de séquences d'ADN et d'ARN spécifiques de genres et d'espèces; dispositifs de détection de biomolécules de diagnostic et de séquences d'ADN à des fins médicales cliniques; dispositifs d'analyse pour l'identification de bactéries à usage médical. (1) Évaluation de la conception du produit; recherches scientifique dans le domaine de la génétique et du génie génétique; recherches technologiques dans le domaine de la génétique et du génie génétique; recherches biologiques; recherches en chimie; recherches médicales; analyse chimique; services de chimiste; services de laboratoires scientifiques, nommément, laboratoires chimiques, de diagnostics médicaux et de recherche scientifique dans le domaine de la génétique et du génie génétique; services de conception et de test d'ADN synthétique à des fins de recherche scientifique; services de synthèse de polynucléotides, à savoir l'ADN et l'ARN à des fins de recherche scientifique; services de stockage des molécules d'acide nucléique, nommément pour l'amplification, l'assemblage et la modification de fragments génétiques, le génotypage, la modification de gènes et l'analyse de cellules, échantillons et systèmes biologiques; services de conservation, de stockage et de traitement de puces à ADN contenant des informations; conception d'ordinateurs pour des tiers; développement d'ordinateurs; conception de logiciels; développement de logiciels; recherche et développement de nouveaux produits pour des tiers; conduite d'études de projets techniques dans le domaine de la génétique et du génie génétique; élaboration (conception) de logiciels; installation de logiciels; maintenance de logiciels; mise à jour de logiciels; location de logiciels informatiques; programmation pour ordinateurs; analyse de systèmes informatiques; conception de systèmes informatiques; services de conseillers en matière de conception et de développement de matériel informatique; numérisation de documents; logiciel-service (SaaS) pour appareils et instruments de laboratoire à usage scientifique pour effectuer la synthèse de polynucléotides, à savoir l'ADN et l'ARN; fournisseur d'informatique en nuage pour le stockage de données; services de conseil en technologie informatique; services d'hébergement de serveurs; services de conception d'art graphique; services de conception industrielle; authentification d'oeuvres d'art; audits en matière d'énergie; stockage électronique de données pour l'archivage de dossiers personnels, de dossiers médicaux et des résultats de recherches scientifiques dans le domaine de la génétique et du génie génétique. (2) Services médicaux, nommément services d'analyses d'ADN à des fins médicales, d'administration de tests médicaux, d'examens médicaux à des fins de diagnostic ou de traitement, d'examens médicaux en matière de diagnostic et de traitement des maladies, services médicaux dans les domaine de l'oncologie et d'administration de tests génétiques à des fins médicales; services vétérinaires; assistance médicale, nommément fourniture d'informations médicales dans le domaine de la génétique et du génie génétique; chirurgie esthétique; services hospitaliers; services d'analyses médicales fournis par des laboratoires médicaux à des fins diagnostiques et thérapeutiques; consultation génétique; consultation en matière de pharmacie.

83.

DNA SCRIPT

      
Numéro de série 79348270
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2024-02-27
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; protein in raw material form for scientific research Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use Apparatus and instruments for laboratory and scientific use for polynucleotide synthesis in the field of DNA and RNA, namely, pipetors, liquid handlers, laboratory columns for chemical synthesis, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory research instruments for DNA analysis, as well as parts and accessories for such apparatus and instruments, namely, laboratory glassware in the nature of bottles, flasks, cartridges, vials, reaction plates, synthesis supports, and reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; Apparatus and instruments for laboratory and scientific use in using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems, namely, laboratory devices for detecting genetic sequences, scientific apparatus and instruments for measuring relative DNA, RNA and protein, electrical equipment for the genetic modification of cells for research purposes, laboratory apparatus and instruments for extracting nucleic acid; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory apparatus and instruments for extracting nucleic acid; computer hardware and recorded and downloadable computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and recorded and downloadable computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and recorded and downloadable computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and recorded and downloadable computer software for use in preserving, storing or processing DNA chips containing information; biochips for scientific research purposes and data storage purposes DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use ; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases; analysis devices for identification of bacteria for medical use Technical evaluations concerning design being engineers' services; scientific research; technical research in the field of polynucleotide synthesis; biological research; chemical research; medical research; chemical analysis; chemistry services, namely, research and laboratory analysis in the field of chemistry; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA synthesis for scientific research purposes; scientific and medical laboratory services, namely, encoding or processing DNA chips containing information and data; design of computers for third parties; computer hardware development; software design; software development; research and development of new products for third parties; technical research in the field of DNA and RNA, namely, conducting of technical project studies; software development and design; software installation; software maintenance; updating of software; software rental, namely, rental of computer software for operating apparatus and instruments for DNA and RNA synthesis; computer programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS) featuring software for operating apparatus and instruments for DNA and RNA synthesis; cloud computing featuring software for operating apparatus and instruments for DNA and RNA synthesis; advice regarding information technology, namely, installation, maintenance and troubleshooting of computer software; hosting of servers; graphic arts design services; styling being industrial design services; authentication of works of art; energy auditing; electronic data storage Medical services; veterinary services; cosmetic and medical skin care services for beauty and sanitary care purposes; medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; advice with respect to health in the field of DNA and its preservation; consultation with respect to pharmaceuticals

84.

DNA SCRIPT

      
Numéro de série 79348312
Statut Enregistrée
Date de dépôt 2022-05-25
Date d'enregistrement 2024-02-27
Propriétaire DNA SCRIPT (France)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; protein in raw material form for scientific research Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use Apparatus and instruments for laboratory and scientific use for polynucleotide synthesis in the field of DNA and RNA, namely, pipetors, liquid handlers, laboratory columns for chemical synthesis, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory research instruments for DNA analysis, as well as parts and accessories for such apparatus and instruments, namely, laboratory glassware in the nature of bottles, flasks, cartridges, vials, reaction plates, synthesis supports, and reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; Apparatus and instruments for laboratory and scientific use in using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems, namely, laboratory devices for detecting genetic sequences, scientific apparatus and instruments for measuring relative DNA, RNA and protein, electrical equipment for the genetic modification of cells for research purposes, laboratory apparatus and instruments for extracting nucleic acid; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory apparatus and instruments for extracting nucleic acid; computer hardware and recorded and downloadable computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and recorded and downloadable computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and recorded and downloadable computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and recorded and downloadable computer software for use in preserving, storing or processing DNA chips containing information; biochips for scientific research purposes and data storage purposes DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use ; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases; analysis devices for identification of bacteria for medical use Technical evaluations concerning design being engineers' services; scientific research; technical research in the field of polynucleotide synthesis; biological research; chemical research; medical research; chemical analysis; chemistry services, namely, research and laboratory analysis in the field of chemistry; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA synthesis for scientific research purposes; scientific and medical laboratory services, namely, encoding or processing DNA chips containing information and data; design of computers for third parties; computer hardware development; software design; software development; research and development of new products for third parties; technical research in the field of DNA and RNA, namely, conducting of technical project studies; software development and design; software installation; software maintenance; updating of software; software rental, namely, rental of computer software for operating apparatus and instruments for DNA and RNA synthesis; computer programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS) featuring software for operating apparatus and instruments for DNA and RNA synthesis; cloud computing featuring software for operating apparatus and instruments for DNA and RNA synthesis; advice regarding information technology, namely, installation, maintenance and troubleshooting of computer software; hosting of servers; graphic arts design services; styling being industrial design services; authentication of works of art; energy auditing; electronic data storage Medical services; veterinary services; cosmetic and medical skin care services for beauty and sanitary care purposes; medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; advice with respect to health in the field of DNA and its preservation; consultation with respect to pharmaceuticals

85.

ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDE PROBES

      
Numéro d'application EP2021079847
Numéro de publication 2022/090323
Statut Délivré - en vigueur
Date de dépôt 2021-10-27
Date de publication 2022-05-05
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Godron, Xavier
  • Niyomchon, Supaporn
  • Champion, Elise

Abrégé

The present invention is directed to methods and kits for enzymatic synthesis of labeled polynucleotide probes using template-free DNA polymerases.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

86.

NOVEL VARIANTS OF ENDONUCLEASE V AND USES THEREOF

      
Numéro d'application EP2021079254
Numéro de publication 2022/090057
Statut Délivré - en vigueur
Date de dépôt 2021-10-21
Date de publication 2022-05-05
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Loftie-Eaton, Wesley
  • Heinisch, Tillmann
  • Soskine, Mikhael
  • Champion, Elise
  • Godron, Xavier
  • Ybert, Thomas

Abrégé

The present invention relates to novel polypeptides having an endonuclease V activity, and uses thereof.

Classes IPC  ?

  • C12N 9/22 - Ribonucléases
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques

87.

STABILIZED N-TERMINALLY TRUNCATED TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE VARIANTS AND USES THEREOF

      
Numéro d'application EP2021076073
Numéro de publication 2022/063835
Statut Délivré - en vigueur
Date de dépôt 2021-09-22
Date de publication 2022-03-31
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Soskine, Mikhael
  • Champion, Elise
  • Mchale, Daniel

Abrégé

The present invention is directed to terminal deoxynucleotidyl transferase (TdT) variants from a variety of species which have been engineered for increase compactness and enhanced efficiency in incorporating reversibly blocked nucleoside triphosphates into a polynucleotide, especially polynucleotides attached porous solid supports. The invention includes use of such TdTs for synthesizing polynucleotides of any predetermined sequence.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

88.

MASSIVELY PARALLEL ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2021069162
Numéro de publication 2022/013094
Statut Délivré - en vigueur
Date de dépôt 2021-07-09
Date de publication 2022-01-20
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Lachaize, Henri
  • Verardo, Damiano
  • Godron, Xavier

Abrégé

The invention is directed to methods and compositions for inkjet assisted synthesis of a plurality of polynucleotides at reaction sites on a substrate using template-free polymerases, such as, terminal deoxynucleotidyl transferases (TdTs). Compositions of the invention include formulations of synthesis reagents for inkjet delivery including, but not limited to, TdT coupling reaction buffers and 3'-O-protected dNTP monomers.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • B41M 5/00 - Procédés de reproduction ou méthodes de reproduction ou de marquageMatériaux en feuilles utilisés à cet effet
  • C09D 11/38 - Encres pour l'impression à jet d'encre caractérisées par des additifs non macromoléculaires autres que les solvants, les pigments ou les colorants
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

89.

Terminal deoxynucleotidyl transferase variants and uses thereof

      
Numéro d'application 17293017
Numéro de brevet 11859217
Statut Délivré - en vigueur
Date de dépôt 2019-11-13
Date de la première publication 2022-01-06
Date d'octroi 2024-01-02
Propriétaire DNA Script (France)
Inventeur(s)
  • Champion, Elise
  • Loc'H, Jéröme
  • Soskine, Mikhael
  • Sune, Elodie

Abrégé

The present invention is directed to terminal deoxynucleotidyltransferase (TdT) variants that (i) comprise an amino acid sequence that is at least a specified percent identical to an indicated SEQ ID NOs and have at least one substitution at Q455 or at least Q455 plus at least one further substitution at G186, S248, T331, Q390, K394 or H466 (where positions are with respect to SEQ ID NO 1 and functionally equivalent positions in indicated SEQ ID NOs), (ii) are capable of template-free extension of a polynucleotide, and (iii) exhibit enhanced stability or enhanced efficiency in incorporating 3′-0-blocked nucleoside triphosphates into a polynucleotide. The invention is also directed to the use of these TdT variants for synthesizing polynucleotides of any predetermined sequence.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

90.

SYSTEMS, APPARATUS AND KITS FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS

      
Numéro d'application EP2021065904
Numéro de publication 2021/254934
Statut Délivré - en vigueur
Date de dépôt 2021-06-14
Date de publication 2021-12-23
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Martin, Carl
  • Artigue, Marc
  • Creton, Sandrine
  • De Crozals, Gabriel
  • Godron, Xavier
  • Horgan, Adrian
  • Lachaize, Henri
  • Lucky, John
  • Peponnet, Christine
  • Ybert, Thomas

Abrégé

The invention is directed to systems, apparatus and kits for automated synthesis of a plurality of polynucleotides in an array of reaction chambers using a template-free polymerase. In some embodiments, adaptive elements and processes are provided to monitor and control disruption of the synthesis process and fluid movement by enzyme aggregation.

Classes IPC  ?

  • B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

91.

Massively parallel enzymatic synthesis of nucleic acid strands

      
Numéro d'application 17259839
Numéro de brevet 12421628
Statut Délivré - en vigueur
Date de dépôt 2019-07-05
Date de la première publication 2021-10-28
Date d'octroi 2025-09-23
Propriétaire DNA Script (France)
Inventeur(s)
  • Horgan, Adrian
  • Godron, Xavier
  • Ybert, Thomas
  • Nicol, Robert

Abrégé

The invention is directed to methods for massively parallel template-free enzymatic synthesis of a plurality of different polynucleotides of predetermined sequences. In one aspect, methods of the invention employ large scale arrays of reaction sites each associated with at least one working electrode for controlling deprotection and deblocking steps at predetermined user selected sites. In another aspect, the invention provides template-free enzymatic synthesis with proofreading, wherein completed polynucleotides at predetermined reaction sites are sequenced using a sequencing by synthesis technique, particularly employing electrochemically labile blocking groups.

Classes IPC  ?

  • C40B 50/06 - Procédés biochimiques, p. ex. utilisant des enzymes ou des micro-organismes viables entiers
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • G16B 50/00 - TIC pour la programmation d’outils ou de systèmes de bases de données spécialement adaptées à la bio-informatique

92.

TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE VARIANTS AND USES THEREOF

      
Numéro d'application EP2021059861
Numéro de publication 2021/213903
Statut Délivré - en vigueur
Date de dépôt 2021-04-16
Date de publication 2021-10-28
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Soskine, Mikhael
  • Champion, Elise

Abrégé

The present invention is directed to terminal deoxynucleotidyl transferase (TdT) variants from a variety of species which display enhanced efficiency in incorporating reversibly blocked nucleoside triphosphates into a polynucleotide, and to the use of such TdTs in synthesizing polynucleotides of any predetermined sequence.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

93.

METHOD FOR PREPARING 3'-O-AMINO-2'-DEOXYRIBONUCLEOSIDE-5'-TRIPHOSPHATES.

      
Numéro d'application EP2021057835
Numéro de publication 2021/198040
Statut Délivré - en vigueur
Date de dépôt 2021-03-25
Date de publication 2021-10-07
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Wojciechowski, Filip
  • Ybert, Thomas

Abrégé

The invention relates to a method for preparing 3'-O-amino-2'-deoxyribonucleoside- 5'-triphosphates with reduced 3'-hydroxy-2'-deoxyribonucleoside-5'-triphosphate contamination by converting 3'-(N-acetone-oxime)-2'-deoxynucleoside triphosphate to 3'-O- amine-2'-deoxynucleoside triphosphate by treatment with an aryl-oxyamine.

Classes IPC  ?

  • C07H 1/04 - Introduction de radicaux d'acide polyphosphorique
  • C07H 19/10 - Radicaux pyrimidine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
  • C07H 19/20 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques

94.

METHOD AND APPARATUS FOR ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2021054278
Numéro de publication 2021/170524
Statut Délivré - en vigueur
Date de dépôt 2021-02-22
Date de publication 2021-09-02
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Godron, Xavier

Abrégé

The invention is directed to methods and apparatus for parallel enzymatic synthesis of polynucleotides in an array of reaction chambers using a template-free polymerase that has sequence-dependent coupling efficiencies. Whenever sequences causing low efficiency coupling occur at a 3' end of a growing chain of a polynucleotide being synthesized, one or more additional coupling cycles without de-protection steps are inserted into synthesis plans to provide additional time for completing the coupling reaction at that position of the polynucleotide.

Classes IPC  ?

  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

95.

Method for preparing 3′-O-amino-2′-deoxyribonucleoside-5′-triphosphate

      
Numéro d'application 17270409
Numéro de brevet 12065461
Statut Délivré - en vigueur
Date de dépôt 2019-08-29
Date de la première publication 2021-07-15
Date d'octroi 2024-08-20
Propriétaire
  • DNA Script (France)
  • Centre National de la Recherche Scientifique (France)
Inventeur(s)
  • Sarac, Ivo
  • Hollenstein, Marcel

Abrégé

The invention relates to a method for preparing 3′-O-amino-2′-deoxyribonucleoside-5′-triphosphate. It also relates to a solid support functionalized with at least one N-hydroxyphthalimide moiety and uses thereof for protecting 3′-hydroxy group of a 2′-deoxyribonucleoside during synthesis of a nucleoside or a derivative thereof.

Classes IPC  ?

  • C07H 1/04 - Introduction de radicaux d'acide polyphosphorique
  • C07H 21/04 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques avec le désoxyribosyle comme radical saccharide

96.

TEMPLATE-FREE ENZYMATIC POLYNUCLEOTIDE SYNTHESIS USING DISMUTATIONLESS TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE VARIANTS

      
Numéro d'application EP2020086135
Numéro de publication 2021/122539
Statut Délivré - en vigueur
Date de dépôt 2020-12-15
Date de publication 2021-06-24
Propriétaire DNA SCRIPT (France)
Inventeur(s) Ybert, Thomas

Abrégé

The present invention is directed to the use of terminal deoxynucleotidyltransferase (TdT) variants lacking dismutation acivity for template-free enzymatic synthesis of polynucleotides of any predetermined sequence. Such TdT variants permit higher yields of correct sequence polynucleotides.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

97.

CHIMERIC TERMINAL DEOXYNUCLEOTIDYL TRANSFERASES FOR TEMPLATE-FREE ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2020085475
Numéro de publication 2021/116270
Statut Délivré - en vigueur
Date de dépôt 2020-12-14
Date de publication 2021-06-17
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Jaziri, Faten
  • Mchale, Daniel

Abrégé

The invention is directed to compositions and methods for enzymatic template-free synthesis of polynucleotides using terminal deoxynucleotidyl transferases that are chimeras derived from variants from different species.

Classes IPC  ?

  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides

98.

HIGH EFFICIENCY TEMPLATE-FREE ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2020081485
Numéro de publication 2021/094251
Statut Délivré - en vigueur
Date de dépôt 2020-11-09
Date de publication 2021-05-20
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Champion, Elise
  • Soskine, Mikhael
  • Sune, Elodie
  • Ybert, Thomas
  • Godron, Xavier
  • Heinisch, Tillmann

Abrégé

The invention is directed to compositions and methods for enzymatic template-free synthesis of polynucleotides wherein different terminal deoxynucleotidyl transferase (TdT) variants are used to incorporate different 3'-O-reversibly blocked deoxynucleoside triphosphates (dNTPs) into a growing chain. In part, the invention is a recognition and appreciation that different TdT variants can be engineered to preferentially incorporate specific dNTPs with higher efficiency than a single "general purpose" TdT variant used to incorporate all four 3'-O-reversibly blocked dNTPs.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)

99.

Method for synthesizing nucleic acids, in particular long nucleic acids, use of said method and kit for implementing said method

      
Numéro d'application 17070707
Numéro de brevet 11685941
Statut Délivré - en vigueur
Date de dépôt 2020-10-14
Date de la première publication 2021-05-06
Date d'octroi 2023-06-27
Propriétaire DNA Script (France)
Inventeur(s)
  • Ybert, Thomas
  • Gariel, Sylvain

Abrégé

The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
  • C12Q 1/6848 - Réactions d’amplification d’acides nucléiques caracterisées par les moyens d’empêcher la contamination ou d’augmenter la spécificité ou la sensibilité d’une réaction d’amplification

100.

INCREASING LONG-SEQUENCE YIELDS IN TEMPLATE-FREE ENZYMATIC SYNTHESIS OF POLYNUCLEOTIDES

      
Numéro d'application EP2020076315
Numéro de publication 2021/058438
Statut Délivré - en vigueur
Date de dépôt 2020-09-21
Date de publication 2021-04-01
Propriétaire DNA SCRIPT (France)
Inventeur(s)
  • Horgan, Adrian
  • Macevicz, Stephen

Abrégé

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides employing hybridization stringency and/or nuclease digestion for removing failure sequences.

Classes IPC  ?

  • C12P 19/34 - Polynucléotides, p. ex. acides nucléiques, oligoribonucléotides
  • C12Q 1/6844 - Réactions d’amplification d’acides nucléiques
  1     2        Prochaine page